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It is widely accepted that the nucleus tractus solitarii (NTS) is a major integrative 
center for processing sensory information involved in cardiovascular control and other 
autonomic reflexes.  The NTS, through its reciprocal connections with medullary, 
pontine and hypothalamic centers, modulates reflex reactivity creating specific patterns 
of autonomic responses observed in physiological and pathological situations, for 
example, stress, the defense response, exercise, hemorrhage etc. 
Tonic blood pressure regulation involves input from baroreceptor afferents to the 
NTS.  Baroreceptors 
are stretch receptors, 
located in the arterial 
walls mainly in the 
aortic arc and the 
bifurcation of the 
carotid arteries (20).  
These receptors 
increase their activity in 
response to increases 
of arterial pressure 
which distends the 
arterial walls.  Baroreceptor afferents reach the NTS via the vagus and 
glossopharyngeal nerves and activate central neurons of this baroreflex pathway via 
glutamatergic mechanism (Figure 1).  The same nerves also provide afferents from 
Figure 1.  Medullary pathways of the baroreceptor reflex. Abbreviations: GABA,  
J-amino-butyric acid; GLU, glutamate; NTS, nucleus of the solitary tract; CVLM, 
caudal ventrolateral medulla; iRVLM, rostral ventrolateral medulla; AMB, 
nucleus ambiguus; IML, intermediolateral column of spinal cord; SG, 
sympathetic ganglion; IX,. glossopharyngeal nerve;  X, vagal nerve. Modified 








arterial chemoreceptors and cardiopulmonary baro- and chemoreceptors to the NTS. 
Efferent control of the cardiovascular system is provided via two main factors:  
the resistance of the peripheral vasculature and cardiac output, which depends on 
cardiac contractility and heart rate (HR).  According to Ohm's law applied to circulating 
fluids P=RxCO, where P is arterial pressure, R is total peripheral resistance and CO is 
cardiac output.  Cardiac contractility and HR are increased by activation of efferent 
sympathetic nerves releasing norepinephrine, which acts via cardiac E1- adrenergic 
receptors. HR is decreased by efferent vagal fibers releasing acetylcholine operating via 
cardiac muscarinic receptors(20).  Medium and small arteries increase and decrease 
peripheral resistance via vasoconstriction and vasodilation, respectively.  Vascular 
control is mediated via efferent sympathetic vasoconstrictor nerves which are tonically 
active at resting conditions.  The major vasoconstrictor mediator released from efferent 
sympathetic terminals is norepinephrine acting via D1-adrenergic receptors located in 
vascular smooth muscles(20).  Sympathetic vasoconstrictor tone is generated in the 
rostral ventrolateral medulla (RVLM) (Figure 1).  RVLM neurons activate sympathetic 
preganglionic neurons located in the intermediolateral column (IML) of the spinal cord 
via a glutamatergic mechanism.  Efferent axons of the preganglionic neurons terminate 
in the sympathetic ganglia and activate ganglionic neurons via the release of 
acetylcholine operating via nicotinic receptors.  The ganglionic neurons send their 
efferent, postganglionic fibers to the peripheral vasculature and cause vasoconstriction 
via D1-adrenergic receptors.  At rest the efferent sympathetic nerves generate tonic 
vasoconstriction.  Increases and decreases in this efferent sympathetic tone result in 
vasoconstriction and vasodilation, respectively.  
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Tonic afferent traffic from arterial baroreceptors and tonic efferent sympathetic 
tone mediate constant regulation of arterial pressure via corrections of efferent 
sympathetic (and cardiac vagal) activity mediated by medullary cardiovascular centers 
illustrated in Figure 1.  For example, increases in arterial blood pressure increase 
afferent baroreceptor traffic, which activate primary central neurons and interneurons 
located in the NTS via a glutamatergic mechanism. NTS neurons activate inhibitory 
GABA-ergic neurons located in the caudal ventrolateral medulla (CVLM) also via a 
glutamatergic mechanism.  Activated CVLM neurons inhibit RVLM neurons via the 
release of GABA from their axons terminating in the RVLM; this decreases efferent 
sympathetic tone which allows peripheral arteries to dilate, decrease peripheral 
resistance and decrease arterial pressure toward normal values.  In contrast, decreases 
in arterial pressure, cause unloading (relaxation) of arterial baroreceptors which 
decreases afferent activation of NTS neurons, decreases activation of CVLM and 
reduces tonic baroreceptor inhibition of sympathetic vasoconstrictor tone generated in 
the RVLM.  This allows for the increase of efferent sympathetic vasoconstriction, 
increase in peripheral resistance and increase of arterial pressure back toward normal 
values. 
Although most of the efferent sympathetic fibers supplying the peripheral 
vasculature mediate vasoconstriction (releasing norepinephrine and to a lesser extent 
ATP and NPY) some sympathetic efferents may produce active vasodilation in a 
regionally specific manner(10; 13; 20; 21; 43; 57).  For example, the iliac vasculature may be 
actively dilated via the release of NO from efferent sympathetic nerves(21; 57) or by 
epinephrine which was previously absorbed from the circulation by sympathetic 
terminals(10).  Sympathetic vasodilation may be provided also by calcitonin gene related 
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peptide (CGRP) or adenosine which is generated by ectonucleotidases from neuronally 
released ATP(13; 43; 94).  These vasodilatory mechanisms, which oppose the prevailing 
efferent sympathetic vasoconstriction contribute to the fine tuning of regional 
vasculature and to specific patterns of autonomic responses, which require the 
redistribution of blood between vascular beds.   
An important sympathetic output which provides humoral control of regional 
vascular beds is the adrenal medulla.  Chromaffin cells of the adrenal medulla are 
modified sympathetic ganglionic neurons and as such they are activated by 
preganglionic nerves that release acetylcholine operating via nicotinic receptors(20).  
Although the activated adrenal medulla releases epinephrine and norepinephrine (in 
ratio of ~4:1), the main adrenergic effect is provided by circulating epinephrine(31).  The 
majority of circulating norepinephrine is generated by sympathetic nerve terminals, 
therefore, the relatively small amount of norepinephrine released from the adrenal 
medulla is negligible.  Epinephrine causes peripheral vasodilation via activation of E2-
adrenergic receptors. Differential regional effects of circulating epinephrine depend on 
differential distribution of E2-adrenergic receptors in different vascular beds(90).  These 
receptors are preferentially expressed in the muscle vascular bed which contributes to 
active vasodilation of the muscle vasculature, for example during stress or the 
hypothalamic defense response(93).   
 The other important humoral vasoactive factor controlled by the baroreflex 
mechanisms is vasopressin which is a potent vasoconstrictor operating via peripheral 
V1 receptors(17).  Vasopressin is synthesized in the magnocellular portion of 
hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei(17; 20).  From these 
hypothalamic nuclei vasopressin is delivered via descending axons to the posterior part 
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of the pituitary gland and released into the circulation. Under normal, resting conditions 
vasopressin is tonically inhibited/restrained by the baroreflex mechanism shown in 
Figure 2.   Therefore 
normal, resting levels of 
vasopressin remain low, 
usually between 1 - 4 
pg/ml(17; 32; 53; 54).  The 
tonic baroreflex inhibition 
of vasopressin release is 
provided mainly via a 
multisynaptic, 
glutamatergic pathway  
which begins in the NTS 
neurons and then travels via the locus ceruleus and diagonal band of Broca reaching 
GABA-ergic neurons located in the periphery of the hypothalamic paraventricular 
nucleus (Figure 2)(20).  It was also postulated that inhibition of vasopressin release may 
involve inhibition of noradrenergic CVLM neurons by NTS GABA-ergic interneurons 
activated by afferent baroreflex traffic.  These CVLM neurons are believed to tonically 
facilitate vasopressin release under normal conditions(20).  Decreases in arterial blood 
pressure unload baroreceptors and decrease baroreceptor inhibition of vasopressin 
release.  This results in disinhibition of magnocellular PVN and SON neurons which 
release vasopressin into the posterior pituitary gland and from there into the circulation. 
The activity of basic medullary cardiovascular centers is modulated by 
descending (mostly hypothalamic) and ascending (spinal) projections(58; 65).  Descending 
Figure 2.  Baroreflex control of vasopressin release.   GABA, J-amino-
butyric acid; NE, norepinephrine; NTS, nucleus of the solitary tract; 
CVLM, caudal ventral lateral medulla; RVLM, rostral ventral lateral 
medulla; IML,  intermediolateral cell column; LC, locus ceruleus; DBB, 
diagonal band of Broca;  PVN, paraventricular nucleus; SON supraoptic 
nucleus; IX, glossopharyngeal nerve; vagal nerve.  Modified from 




fibers, mostly from hypothalamic paraventricular and dorsomedial nuclei, or ascending 
spinal afferents may inhibit baroreflex activity at the level of the NTS.  Descending 
hypothalamic projections to RVLM and IML may also directly modulate regional 
sympathetic drive.  Baroreflex mechanisms together with the descending and ascending 
(afferent) projections create specific patterns of autonomic responses.  For example,  
during stimulation of the hypothalamic defense area (which mimics a stress response) 
the descending hypothalamic projections activate intrinsic NTS GABA-ergic neurons 
which inhibit glutamatergic transmission in the baroreflex arc(40; 49).  Similar 
modulation/resetting of baroreflex mechanisms occurs during exercise via both 
descending (central command) and ascending projections from muscle receptors(58; 62; 
63).  This allows for a simultaneous increase of arterial pressure and heart rate and 
contractility which is a key cardiovascular adjustment which increases cardiac output 
and skeletal muscle perfusion in these situations.  The other crucial adjustment 
increasing muscle blood flow during stress is the redistribution of blood from the visceral 
to the muscle vascular bed.  This is achieved via simultaneous vasoconstriction of 
visceral vascular beds and active muscle vasodilation, usually measured as hindlimb 
vasodilation.  The active hindlimb vasodilation is mediated mostly via E2-adrenergic 
receptors preferentially located in the muscle vascular beds(90), which are activated by 
epinephrine released from the adrenal medulla. This  mechanism is crucial for stress 
related hindlimb vasodilation in rats(2; 93) whereas in dogs, cats and humans sympathetic 
cholinergic vasodilation may also contribute to this response(39; 46; 60).  Epinephrine may 
be also released into the hindlimb vasculature from sympathetic terminals which 
previously absorbed circulating epinephrine(10; 22).  It has been also reported that 
sympathetic nerves supplying the hindlimb vasculature may release nitric oxide(21; 57).  
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Similar mechanisms as those described above may create other differential patterns of 
regional cardiovascular responses; for example, during hemorrhage, thermoregulatory 
adjustments and other physiological and pathological situations(50; 78; 91). 
Adenosine as a neuromodulator in central cardiovascular control 
Numerous studies from our laboratory and by others showed that purinergic 
mechanisms (operated by adenosine and its nucleotides) are involved in cardiovascular 
control at the level of the NTS(4; 5; 7; 8; 15; 37; 51; 52; 55; 72; 77; 82; 85).  Adenosine operating in the 
NTS originates from the breakdown of ATP, both intra- and extracellularly, and is 
involved under both physiological and pathological conditions.  Under physiological 
conditions neuronally released ATP is broken to adenosine via ectonucleotidases(94).  
This may occur during stress or the hypothalamic defense response(82).  ATP may be 
also neuronally released as a co-transmitter with glutamate in the baroreflex arc at the 
level of the NTS, as suggested by previous studies from our laboratory(70; 74).  Under 
pathological conditions, such as severe hemorrhage, ischemia, and hypoxia, 
intracellular ATP is catabolized to adenosine in hypoxic cells and adenosine is directly 
released into the extracellular space without the contribution of nucleoside transporters 
(56; 84; 89; 92).  Therefore, adenosine is a neuromodulator activated in life threatening 
situations to regain homeostasis.  A recent paper from our laboratory showed that 
adenosine operating via both A1 and A2a receptors located in the NTS contribute to the 
paradoxical renal sympathoinhibition and cardiac slowing observed in the hypotensive 
stage of severe hemorrhage(78).  In addition, the same study showed that both A1 and 
A2a adenosine receptor subtypes may exert tonic effects on hemodynamic and 
sympathetic variables under control conditions.  Thus adenosine operating in the NTS 
may play an important role as a neuromodulator of reflex control of the circulation under 
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normal, physiological conditions.  In a recent study from our laboratory we found that A1 
adenosine receptor stimulation in the NTS resets baroreflex functions towards higher 
mean arterial pressure (MAP)(71). 
A1 adenosine receptor activation in the central nervous system, including the 
NTS, stimulates an inhibitory G protein resulting in decreased cAMP formation, lower 
intracellular Ca2+ levels and thus decreased neurotransmitter release from synaptic 
terminals(59).  A2a receptor activation operates in a reciprocal fashion, activating a 
stimulatory G protein, increasing cAMP and Ca2+ influx and consequently facilitating 
neurotransmission(59).  Postsynaptic A1 and A2a adenosine receptors may also inhibit 
and activate neurons, respectively(59).  Therefore selective activation of adenosine A1 
and A2a receptor subtypes in the NTS often, although not always, evokes reciprocal 
hemodynamic and sympathetic responses.   
Selective activation of NTS A1 adenosine receptors typically evokes pressor and 
sympathoexcitory responses consistent with the inhibition of glutamatergic transmission 
at the baroreflex arc(4; 8; 76).  For example, Scislo and O’Leary showed that sino-aortic 
denervation plus vagotomy as well as blockade of glutamatergic transmission in the 
NTS eliminated the pressor and sympathoactivatory responses(76).  A recent study from 
our laboratory directly confirmed that activation of NTS A1 adenosine receptors resets 
regional sympathetic and heart rate baroreflex functions toward higher MAP which is 
consistent with presynaptic inhibition of glutamate release from baroreceptor 
terminals(71). 
In contrast, selective activation of NTS A2a adenosine receptors, as well as 
nonselective activation of these receptors with adenosine evokes baroreflex-like 
responses, i.e. decreases in MAP and HR. Numerous data suggested that presynaptic 
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A2a adenosine receptors may facilitate release of glutamate from baroreceptor afferents 
terminating in the NTS(4; 7; 8; 15; 51; 52; 85; 88).  However, analysis of regional sympathetic 
responses to selective stimulation of NTS A2a adenosine receptors leads to the opposite 
conclusions.  Although the stimulation inhibited renal sympathetic nerve activity (RSNA), 
which is consistent with activation of baroreflex pathway, lumbar sympathetic nerve 
activity (LSNA) did not change significantly, whereas preganglionic adrenal sympathetic 
nerve activity (pre-ASNA) increased, which is inconsistent with the effects evoked by 
activation of the baroreflex pathway(73; 74).  It should be stressed that all these 
sympathetic outputs were uniformly inhibited when arterial baroreceptors were 
stimulated with increases in MAP(68).  In addition, bilateral sinoaortic denervation plus 
vagotomy, essentially the denervation of baroreceptor input to the NTS, did not affect 
the depressor and renal sympathoinhibitory responses mediated via NTS A2a adenosine 
receptors(74).  Also, blockade of glutamatergic transmission in the NTS did not abolish 
the baroreflex-like response to stimulation of NTS A2a adenosine receptors(75).  Finally, a 
recent study from our laboratory directly confirmed that selective stimulation of NTS A2a 
adenosine receptors did not reset baroreflex functions towards lower MAP, which would 
be expected if A2a adenosine receptors facilitated baroreflex transmission(37).  This study 
strongly suggested that hemodynamic and regional sympathetic responses to 
stimulation of NTS A2a adenosine receptors are mediated via non-baroreflex 
mechanisms.  
Typically, NTS A1 and A2a adenosine receptors exert counteracting 
hemodynamic effects: increases and decreases in MAP and RSNA as well as 
vasoconstriction and vasodilation, respectively(4; 8; 47; 73; 74; 76).  Interestingly, despite of 
those reciprocal effects both receptor subtypes preferentially increase sympathetic 
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nerve activity directed to the adrenal medulla(74-76).  This suggests that adenosine 
operating in the NTS via both receptor subtypes may preferentially activate the adrenal 
medulla, release epinephrine into the circulation and exert vasodilation in the muscle 
vascular bed via activation of E-adrenergic receptors.  Yardley and Hilton suggested 
that in the rat epinephrine release is a major vasodilator of the hindlimb vasculature in 
response to stress or stimulation of the hypothalamic defense area(93).  These data 
taken together suggest that both A1 and A2a adenosine receptors may be involved in 
mechanisms mediating stress and the defense response. 
Adenosine and autonomic response to stress 
The hypothalamic defense response (HDR) is an experimental model which 
allows one to study stress induced patterns of autonomic responses in anesthetized 
animals.  These patterns may be evoked by precisely controlled electrical or chemical 
stimulation of forebrain, diencephalic and midbrain stress related structures: central 
amygdala, posterior/dorsomedial hypothalamus and periaqueductal grey, 
respectively(14; 20; 24; 26; 79; 93).  The hypothalamic defense response consists of increases 
in MAP, HR, efferent sympathetic nerve activity, pulmonary ventilation and is 
accompanied with powerful vasodilation in the muscle vascular bed, especially in the 
hindlimb vasculature(93).  These responses are at least partially mediated via inhibition 
of baroreflex mechanisms at the level of the NTS(40; 49).  Several studies from Spyer's 
laboratory showed that adenosine contributes to the pressor component of HDR.  For 
example, blockade of A1 adenosine receptors via microinjections of the selective 
antagonist, 8-Cyclopentyl-1,3-dipropylxanthine, into the IV ventricle, in close proximity to 
the NTS, attenuated the pressor component of HDR(80).  The blockade of 
ectonucleotidases, which prevents the conversion of neuronally released ATP to 
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adenosine in the NTS, also attenuated the pressor component of HDR(82).  This study 
strongly suggested that during HDR, ATP is neuronally released into the NTS and 
becomes a source of adenosine which subsequently facilitates the pressor response.  
Finally, the most recent paper from this group directly confirmed that adenosine levels in 
the NTS increase during HDR(19).  However, the contribution of NTS adenosine receptor 
subtypes to hindlimb vasodilation has not been studied in respect to HDR.  Taking into 
consideration that the activation of both A1 and A2a adenosine receptors located in the 
NTS preferentially increases sympathetic efferent activation of the adrenal medulla(73; 74; 
76), and that E-adrenergic mechanism is the crucial mechanism of hindlimb vasodilation 
in rats(93) it is likely that adenosine operating in the NTS may significantly contribute to 
the stress-related redistribution of blood from the viscera to the skeletal muscle. 
Previous studies from our laboratory indicated that activation of NTS A2a 
adenosine receptors elicits preferential vasodilation in the iliac vascular bed directed 
mostly to the hindlimb in the rat(7).  The subsequent study showed that the hindlimb 
vasodilation was mediated by both neural and humoral mechanisms(42).  After ȕ-
adrenergic blockade, NTS A2a receptor mediated responses turned from depressor to 
pressor and from hindlimb vasodilation to hindlimb vasoconstriction.  Lumbar 
sympathectomy as well as bilateral adrenalectomy attenuated the hindlimb vasodilation. 
Combined lumbar sympathectomy and bilateral adrenalectomy abolished the response.  
In addition, a recent study from our laboratory showed that activation of NTS A1 
adenosine receptors inhibits baroreflex mechanisms(71), similarly as it occurs during 
HDR(49).  Taken together the results of Spyer’s group and those from our laboratory, 
these data suggest that adenosine acting via A1 receptors in the NTS may contribute to 
the pressor component of HDR, whereas adenosine A2a (and to some extent A1) 
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Figure 3.  Mean arterial pressure (MAP), Iliac blood flow (IBF), and iliac vascular 
conductance (IVC) responses to microinjection of CPA (330 pmol/50nL), an A1 
adenosine receptor agonist, into the subpostremal NTS.  Intact (INT), ȕ-adrenergic 
blockade (ȕX), bilateral adrenalectomy (ADX), lumbar sympathectomy (LX), and 
combined adrenalectomy plus lumbar sympathectomy (ADX + LX).  Microinjections of 
CPA denoted by vertical arrow.  Reprinted from McClure et al. 2005 (47). 
receptors located in the NTS may contribute to HDR related hindlimb vasodilation via a 
E2-adrenergic mechanism(7; 19; 42; 49; 71; 80; 82).  However, these hypotheses have yet to be 
directly proven.  
NTS A1 adenosine receptors and counteracting vascular effects 
Previous studies from our laboratory suggested that adenosine A1 receptors may 
also contribute to HDR related hindlimb vasodilation, as selective stimulation of these 
receptors preferentially activates sympathetic output directed to the adrenal medulla(76).  
This may result in the release of epinephrine and E-adrenergic vasodilation in the 
hindlimb vasculature similar to that observed following selective stimulation of NTS A2a 
adenosine receptors(42).  However, the cardiovascular actions of NTS A1 adenosine 
receptors seem to be more complex than that elicited by NTS A2a adenosine receptor 
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subtypes.  NTS A1 adenosine receptors, in addition to the aforementioned potential E-
adrenergic vasodilation, exert mostly pressor and vasoconstrictor effects; selective 
activation of these receptors elicits uniform, although differential, regional 
sympathoactivation.  These counteracting mechanisms are most likely responsible for 
the relatively high variability of MAP responses triggered by selective activation of NTS 
A1 adenosine receptors: pressor, but also biphasic and depressor responses were 
observed(76).  The competition between neural vasoconstriction and epinephrine 
mediated vasodilation may be especially powerful in the hindlimb vascular bed where 
expression of E-adrenergic receptors is relatively greater than in other vascular beds 
(90).  In the recent study from our laboratory I confirmed this hypothesis showing that 
selective stimulation of NTS A1 adenosine receptors evokes simultaneous ȕ2-adrenergic 
vasodilation and sympathetic/humoral vasoconstriction in the iliac vascular bed with 
prevailing pressor and vasoconstrictor responses(47).  The variability of the responses 
(pressor vs. depressor and iliac vasoconstriction vs. vasodilation) were relatively high in 
intact animals: ~70% pressor and ~65% iliac vasoconstrictor responses were observed. 
These results were similar to those previously observed in our laboratory(76).  The initial 
variability of the responses observed in intact animals (INT) was completely eliminated 
following ȕ-adrenergic blockade (ȕX) as well as following bilateral adrenalectomy 
(ADX); under these experimental conditions only pronounced increases in MAP and 
decreases in iliac vascular conductance (IVC) were observed (Figures 3 & 4).  Bilateral 
lumbar sympathectomy attenuated the pressor and vasoconstrictor responses observed 
in the intact group; however, combined bilateral adrenalectomy plus sympathectomy 
(ADX+LX) did not abolish the responses. Instead, relatively large increases in MAP and 
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Figure 4.  Integral responses of MAP, IBF, and IVC evoked 
by microinjection CPA (330 pmol) into the NTS.  
Abbreviations the same as in Figure 3.  *Different versus 
intact (INT) group (P < 0.05).  Reprinted from McClure et al. 
2005 (47).
increases in MAP in the ADX+LX group were not different from those observed in intact 
animals, whereas iliac vasoconstriction was approximately 4 fold greater in comparison 
to the intact group and similar to that observed following EX and ADX (Figure 4).  Since 
a powerful vasoconstriction persisted after the removal of sympathetic innervation 
combined with bilateral adrenalectomy this response must be mediated via unknown 
humoral factors released upon stimulation of NTS A1 adenosine receptors.  Three major 
vasoconstrictor substances may be 
potentially released into the 
circulation under these conditions: 
vasopressin, angiotensin II and 
norepinephrine.  Since the release 
of vasopressin is tonically inhibited 
via baroreflex mechanisms(20), the 
attenuation/resetting of the 
baroreflex may remove this restraint 
and trigger the release of 
vasopressin into the circulation.  In 
support of this hypothesis, a recent 
study from our laboratory showed 
that selective stimulation of A1 
adenosine receptors in the NTS resets the baroreflex control of the circulation to a 
higher MAP(71).  As previously mentioned the stimulation of NTS A1 adenosine receptors 
increases RSNA(76).  The increase in RSNA facilitates the release of renin into the 
circulation, which is subsequently transformed into angiotensin II(23).  The circulating 
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angiotensin II may contribute to the iliac vasoconstriction via AT1 angiotensin receptors.  
Finally, since the stimulation of NTS A1 adenosine receptors increases activity of 
various sympathetic outputs it is possible that norepinephrine released from synaptic 
terminals, other than those directed to the hindlimb, may reach the iliac vascular bed via 
circulating blood and contribute to the iliac vasoconstriction.  Taking into consideration 
that ȕ2-adrenergic receptors, V1 vasopressin receptors, and AT1 angiotensin II receptors 
may be differentially expressed in various vascular beds and that regional vascular beds 
differentially respond to stimulation/inhibition of those receptors(1; 16; 27-29; 34; 36; 45; 90), the 
contribution of neural and humoral factors to regional vascular responses (iliac vs. 
mesenteric vs. renal) may likely be different.  Since NTS A1 adenosine receptors 
contribute to the pattern of autonomic response to stress/HDR it is especially interesting 
if these receptors also contribute to the redistribution of blood from the visceral to 
muscle vasculature, which is a key component of stress/HDR-related cardiovascular 
adjustments(80-82; 93).  All the above hypotheses are addressed in this dissertation. 
Experimental plan 
During life threatening situations such as stress, hypoxia, ischemia, or severe 
hemorrhage, adenosine is released into the central nervous system including the 
nucleus tractus solitarii (NTS), a primary integrative center for cardiovascular and other 
autonomic reflexes.  Selective activation of A1 adenosine receptors in the NTS evokes 
inhibition of baroreflex transmission, differential regional sympathoactivation 
(adrenal>renallumbar) and variable hemodynamic responses with prevailing pressor 
and vasoconstrictor responses.  These receptors facilitate the hypothalamic defense 
response, and therefore may contribute to the redistribution of blood from the visceral to 
the muscle vascular beds.  My previous study showed that stimulation of A1 adenosine 
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receptors in the NTS triggers in iliac vascular bed E2-adrenergic vasodilation opposed 
by vasoconstriction mediated by efferent sympathetic nerves and an unknown 
vasoconstrictor factor(s).  Therefore, the goal of this dissertation was to identify these 
humoral vasoconstrictor(s) and to evaluate the relative role of all vasoactive factors 
triggered by NTS A1 adenosine receptors in regional vascular beds.  
Aims of dissertation: 
1. To determine which humoral vasoconstrictor(s) (vasopressin, angiotensin II, and 
/or norepinephrine) oppose ȕ2-adrenergic vasodilation in the iliac vascular bed 
evoked by selective stimulation of A1 adenosine receptors in the NTS. 
2. To determine if A1 adenosine receptor stimulation contributes to the redistribution 
of blood flow from visceral (mesenteric and renal) to somatic (iliac) vascular 
beds; specifically, if vasoconstrictor factors prevail over E2-adrenergic 
vasodilation in visceral vs. somatic vascular beds. 
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CHAPTER 1  
Vasopressin is a major vasoconstrictor involved in hindlimb vascular responses 
to stimulation of adenosine A1 receptors in the nucleus of the solitary tract 
ABSTRACT 
Our previous study showed that stimulation of adenosine A1 receptors located in 
the nucleus of the solitary tract (NTS) exerts counteracting effects on the iliac vascular 
bed: activation of the adrenal medulla and ȕ-adrenergic vasodilation versus 
vasoconstriction mediated by neural and unknown humoral factors.  In the present study 
we investigated the relative contribution of three major potential humoral 
vasoconstrictors: vasopressin, angiotensin II and norepinephrine in this response.  In 
urethane/chloralose anesthetized rats we compared the integral changes in iliac 
vascular conductance evoked by microinjections into the NTS of the selective A1 
receptor agonist, N6-cyclopentlyadenosine (CPA, 330 pmol in 50 nl) in intact (INT) 
animals and following: V1 vasopressin receptor blockade (VX), angiotensin II AT1 
receptor blockade (ATX), bilateral adrenalectomy + ganglionic blockade (ADX+GX, 
which eliminated the potential increases in circulating norepinephrine and epinephrine), 
ADX+GX+VX and ADX+GX+VX+ATX.  In INT animals, stimulation of NTS A1 adenosine 
receptors evoked typical variable responses with prevailing pressor and vasoconstrictor 
effects.  VX reversed the responses to depressor ones.  ATX did not significantly alter 
the responses.  ADX+GX accentuated pressor and vasoconstrictor responses whereas 
ADX+GX+VX and ADX+GX+VX+ATX virtually abolished the responses.  Stimulation of 
NTS A1 adenosine receptors increased circulating vasopressin over 4-fold (26.4±10.4 
vs. 117.0±19 pg/ml).  These data strongly suggest that vasopressin is a major 
vasoconstrictor factor opposing ȕ-adrenergic vasodilation in iliac vascular responses 
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triggered by stimulation of NTS A1 adenosine receptors whereas angiotensin II and 
norepinephrine do not contribute significantly to the vasoconstrictor responses. 
INTRODUCTION 
It is now widely accepted that adenosine operating via A1 and A2a receptors 
modulates neural cardiovascular control at the level of the nucleus tractus solitarii (NTS) 
and other brainstem cardiovascular centers(4; 7; 8; 44; 72; 77; 82; 86).  Under normal, 
physiological conditions a natural source of adenosine is ATP released synaptically 
from neurons as well as from glial cells activated by neighboring neurons(9; 13; 19; 33; 82). 
This extracellular ATP is catabolized via ectonucleotidases to adenosine which further 
acts more broadly as a neuromodulator operating via pre or postsynaptic A1 and A2a 
adenosine receptor subtypes(13; 59; 82; 94).  Under pathological conditions such as 
ischemia, hypoxia, and severe hemorrhage a global release of adenosine from many 
cell types occurs via the breakdown of intracellular ATP(56; 89; 92).  Thus, adenosine which 
is generated in or released into the extracellular space under physiological or 
pathological conditions acts not via specific synapses in specific neuronal pathways but 
rather spatially, reaching all adenosine receptor subtypes in the vicinity; this may 
resemble signaling via diffusive neurotransmitters/neuromodulators like nitric oxide or 
carbon monoxide.  This spatial aspect of the action of naturally released adenosine 
seems especially important for the NTS where groups of functionally different neurons 
usually overlap allowing for "adenosine crosstalk".  Specific physiological effects 
exerted via nonselective, spatial spread of adenosine in the NTS may depend on 
differential expression of adenosine receptor subtypes on functionally distinct NTS 
neurons/terminals, as we suggested previously(72; 77). 
In the central nervous system adenosine may inhibit or facilitate release of 
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neurotransmitters from synaptic terminals as well as directly inhibit or activate neurons 
via pre- and postsynaptic A1 or A2a receptors, respectively(13; 59; 72; 77).  Since A1 vs. A2a 
adenosine receptors exert contrasting effects on central neurons/terminals reciprocal 
effects are usually, although not always, observed in response to selective stimulation 
of the two receptor subtypes.  NTS A1 adenosine receptor stimulation predominately 
yields differential regional sympathoactivation  (adrenal>renallumbar) and pressor 
responses(4; 8; 71; 76). In contrast, NTS A2a receptor stimulation typically evokes depressor 
responses accompanied by contrasting regional sympathetic responses: decreases in 
renal (RSNA), no changes in lumbar (LSNA) and increases in preganglionic adrenal 
(pre-ASNA) sympathetic nerve activity(4; 8; 37; 73-75).  Note that whereas stimulation of 
NTS A1  and A2a receptors evoke contrasting changes in RSNA and LSNA, both 
adenosine receptor subtypes activate the sympathetic output to the adrenal 
medulla(74;76).   
Recent studies from our laboratory showed that the pressor and 
sympathoexcitatory responses evoked by stimulation of NTS A1 adenosine receptors 
are mediated mostly via inhibition of baroreflex mechanisms at the level of the NTS 
whereas hemodynamic and differential sympathetic responses evoked by stimulation of 
NTS A2a adenosine receptors are mediated mostly via activation of non-baroreflex 
mechanisms(37; 71; 74-76).  It should be stressed that A1 adenosine receptors may also 
modulate non-glutamatergic, non-baroreflex mechanisms operating in the NTS. For 
example, sinoaortic denervation or ionotropic glutamatergic blockade abolished A1-
adenosine-receptor-mediated increases in RSNA and LSNA whereas this attenuated, 
but did not abolish, the increases in pre-ASNA(76).  The activation of pre-ASNA which 
persisted after sinoaortic and the glutamatergic blockade was most likely mediated via 
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A1 adenosine receptor modulation of non-glutamatergic pathways descending into the 
NTS from higher structures, such as from hypothalamic paraventricular and/or 
dorsomedial nuclei(26; 65; 87). A1 adenosine receptors located on these descending 
nonglutamatergic pathways and/or NTS interneurons could selectively activate the 
sympathetic output to the adrenal medulla (but not RSNA and LSNA) via disinhibition of 
direct NTS-RVLM pathways(20).  NTS A1 adenosine receptors may also modulate the 
control of heart rate (HR) via both baroreflex and non-baroreflex mechanisms(71; 76).  
Taken together these observations strongly suggest that A1 adenosine receptors are 
differentially located on functionally different NTS neurons/terminals which are mostly, 
but not exclusively glutamatergic and involved in the baroreflex arch.  
 Although selective stimulation of NTS A1 adenosine receptors evokes 
predominantly pressor responses(4; 8), occasionally biphasic or even depressor 
responses are observed(76).  This variability of the responses is a natural consequence 
of simultaneous activation of at least two counteracting mechanisms: sympathetic 
vasoconstriction and E-adrenergic vasodilation mediated via epinephrine released from 
the activated adrenal medulla.  Since E-adrenergic receptors are preferentially located 
in the muscle vascular(90) bed and both pre-ASNA and LSNA increase upon stimulation 
of NTS A1 adenosine receptors it was likely that these two counteracting factors may 
significantly contribute to the variability of the iliac vascular responses.  We confirmed 
this hypothesis in our recent study by showing that removal of the vasodilatory 
mechanism (via bilateral adrenalectomy as well as peripheral blockade of E-adrenergic 
receptors) abolished the variability of the responses normally observed in intact animals 
and markedly increased the pressor and hindlimb vasoconstrictor responses(47).  In 
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contrast, bilateral lumbar sympathectomy tended to increase the vasodilatory 
component of the responses although the variability still persisted.  To our surprise, 
following combined adrenalectomy plus lumbar sympathectomy a marked, consistent 
vasoconstrictor component still persisted suggesting that some unknown humoral 
vasoconstrictor factor(s) are involved(47).   
The most likely humoral candidates contributing to the iliac vasoconstriction are 
vasopressin, angiotensin II and norepinephrine.  Since activation of A1 adenosine 
receptors may inhibit glutamate release in baroreflex pathway at the level of the NTS(71; 
76), and given that the NTS is a crucial, primary relay station for tonic baroreflex 
inhibition of vasopressin release(20; 66; 83) it is likely that the activation of A1 adenosine 
receptors may inhibit the baroreflex restraint of vasopressin release.  When released, 
vasopressin could evoke powerful peripheral vasoconstriction.  However, whether A1 
adenosine receptors are present on those NTS baroreflex neurons/terminals which 
inhibit the release of vasopressin is unknown. The present study was designed to test 
this hypothesis.   
Since renal sympathetic nerve activity (RSNA) directed to the kidney has been 
shown to increase following stimulation of NTS A1 adenosine receptors(76), this may 
facilitate the renin/angiotensin mechanism leading to humoral vasoconstriction of the 
hindlimb vasculature mediated via AT1 angiotensin II receptors(23).  In addition, since  
stimulation of NTS A1 adenosine receptors increases the activity of various sympathetic 
outputs(76) it is also possible that circulating norepinephrine released from other synaptic 
terminals may reach the iliac vasculature and cause vasoconstriction.  Therefore, in the 
present study we investigated the extent to which these three potential humoral 
vasoconstrictors (vasopressin, angiotensin II and/or norepinephrine) contribute to NTS-
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A1-adenosine-receptor-elicited iliac vasoconstriction(47).    
MATERIALS AND METHODS 
All protocols and surgical procedures employed in this study were reviewed and 
approved by the institutional Animal Care and Use Committee and were performed in 
accordance with the Guiding Principles in the Care and Use of Animals endorsed by the 
American Physiological Society and published by the National Institutes of Health. 
Design 
This study investigates further the mechanisms responsible for the consistent 
variability of hemodynamic responses elicited by activation of adenosine A1 receptors in 
the NTS(47; 76).  Previously we showed that the variability of the pressor/depressor and 
iliac vasoconstrictor/vasodilator responses is not a simple effect of competitive 
interactions between sympathetic vasoconstriction vs. ȕ-adrenergic vasodilation but 
some unknown, powerful, humoral vasoconstrictor factor(s) are also involved(47).  
Therefore, the present study assessed the relative contribution of potential humoral 
vasoconstricting factors to the iliac vascular responses evoked by selective stimulation 
of NTS A1 adenosine receptors.  Experiments were performed on a total of 102 male 
Sprague Dawley rats.  In 63 rats we compared the relative vasoconstrictor effects 
potentially mediated via vasopressin, angiotensin II, norepinephrine and sympathetic 
innervation of the hindquarters, the effects normally opposed by simultaneous ȕ-
adrenergic vasodilation mediated via activation of the adrenal medulla.  In an additional 
20 rats, respective time controls were performed and in 6 rats the effectiveness of 
vasopressin and angiotensin II receptor blockades was assessed.  These functional 
experiments strongly suggested that the major vasoconstrictor factor triggered by 
activation of adenosine A1 receptors in the NTS may be vasopressin.  Therefore, in an 
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additional group of 13 animals the levels of circulating vasopressin were evaluated 
before and following microinjections into the NTS of the selective A1 adenosine receptor 
agonist, N6-cyclopentlyadenosine (CPA) or vehicle control.  
Instrumentation and measurements 
All the procedures were described in detail previously(7; 42; 47; 73-76).  Briefly, male 
Sprague-Dawley rats (350-400 g, Charles River) were anesthetized with a mixture of Į-
chloralose (80 mg/kg) and urethane (500 mg/kg, ip), tracheotomized, connected to a 
small animal respirator (SAR-830, CWE, Ardmore, PA) and artificially ventilated with 
40% oxygen 60% nitrogen mixture. Catheterization of the right femoral artery and vein 
were performed to monitor arterial blood pressure and infuse drugs, respectively. 
Arterial blood gases were tested occasionally for appropriate experimental values 
(Radiometer, ABL500, OSM3).  Averaged values measured at the end of each 
experiment were the following:  pH = 7.38±0.01, Po2 = 140.1±3.8 mmHg, and Pco2 = 
36.2±0.7 mmHg.    
From a mid-abdominal incision, the left iliac artery was exposed.  A pulse 
Doppler blood flow velocity transducer was placed around the artery and connected to 
the flowmeter (Baylor Electronics).  From the same mid-abdominal incision in some 
animals, bilateral adrenalectomy or lumbar sympathectomy (L1-L6) was performed. The 
intermesenteric nerves were also severed in sympathectomized animals.  
Arterial blood pressure and iliac flow signals were digitized and recorded with an 
analog-digital converter (Modular Instruments) interfaced to a laboratory computer.  The 
signals were recorded continuously using Biowindows software (Modular Instruments), 




Microinjections into the NTS 
Animals were placed in stereotaxic frame with head tilted down at 45º.  After the 
exposure of the brainstem via dissected atlantoccipital membrane, the animals were 
allowed to stabilize for at 
least 30 min before 
microinjections.  Unilateral 
microinjections of the 
selective A1 adenosine 
receptor agonist  CPA 
(Tocris, 330 pmol) 
dissolved in 50 nl of artificial 
cerebrospinal fluid (ACF) 
were made through 
multibarrel, glass 
micropipettes into the 
medial region of the caudal 
subpostremal NTS as 
described previously(7; 42; 73-
76).  This dose of CPA 
produced the most 
consistent, predominantly 
pressor responses in our 
previous study(76).  The 





















































Figure 5.  Microinjection sites in the caudal subpostremal NTS for all 
experiments.  Schematic diagrams of transverse sections of the 
medulla oblongata from a rat brain.  NTS, nucleus tractus solitarii; AP, 
area postrema;  c, central canal; 10, dorsal motor nucleus of the vagus 
nerve; 12, nucleus of the hypoglossal nerve; ts, tractus solitarius; Gr, 
gracile nucleus; Cu, cuneate nucleus.  Scale is shown at the bottom; 
the number on the left side of the schematic diagram denotes the 
rostro-caudal position in millimeters of the section relative to the obex 
according to the atlas of the rat subpostremal NTS by Barraco et al. (3).  
Microinjection sites were marked with fluorescent dye and are denoted 
with filled symbols for the pressor responses to CPA and corresponding 
open symbols for the depressor responses.  A: microinjections of CPA 
in intact animals (ʀ,ɿ), after vasopressin V1 receptor blockade (VX) (), 
lumbar sympathectomy plus VX (S,U), and after angiotensin II AT1 
receptor blockade (ATX) (Ŷ,Ƒ).  B:  microinjections of CPA after bilateral 
adrenalectomy (ADX) plus ganglionic blockade (GX) (T), following 
ADX+GX+VX (~), after ADX+GX+VX+ATX (,). In experiments 
where vasopressin assay was performed the microinjection sites were 
denoted: + and x for CPA and ACF microinjections, respectively.
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have shown that microinjections of the same amount of ACF into the same site of the 
NTS did not markedly affect mean arterial pressure (MAP), HR, RSNA, LSNA and pre-
ganglionic adrenal (pre-ASNA) sympathetic nerve activity and vascular flows in iliac, 
renal and mesenteric arteries(7; 73-76).  The changes in all these variables were either not 
different from zero or smaller than natural, random fluctuations of these variables over 
the time of measurements.  To avoid the effect of desensitization of A1 adenosine 
receptors, in all experiments only one dose of the agonist was microinjected into left or 
right side of the NTS.  All microinjection sites were marked with fluorescent dye (DiI, 
Molecular Probes) and verified histologically (Figure 5) as described previously(7; 42;73-76). 
We believe that the microinjection technique mimics natural, spatial (not strictly 
synaptic) action of adenosine in the central nervous system as adenosine is naturally 
produced in the intracellular space by ectonucleotidases from extracellular ATP 
(released from neurons and glial cells under physiological conditions)(9; 13; 33; 82; 94) or it is 
directly  released into the intracellular space from ischemic/hypoxic neurons and glial 
cells under pathological conditions(56; 89; 92). 
Experimental protocols 
In a previous study from our laboratory we showed that in addition to sympathetic 
iliac vasoconstriction and E-adrenergic vasodilation some unknown humoral 
vasoconstrictor(s) contribute to the consistent variability of hemodynamic responses 
evoked by selective stimulation of adenosine A1 receptors located in the NTS(47).  This 
conclusion was based on comparing of the responses observed in intact animals and 
following four experimental protocols: 1) E-adrenergic blockade, 2) adrenalectomy, 3) 
lumbar sympathectomy and 4) combined adrenalectomy plus lumbar sympathectomy. 
In the last experimental condition a powerful iliac vasoconstriction was observed 
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indicating that non-sympathetic, humoral vasoconstrictors are involved(47).  The present 
study is a direct extension of our previous findings and focuses on the relative 
contribution to the responses of three potential humoral vasoconstrictors: vasopressin, 
angiotensin II and norepinephrine. 
Six experimental protocols were 
designed, according to the 
diagrams presented in Figure 6. 
Data collected in each protocol 
were compared with responses 
observed in intact group. In 
Protocols 1 and 2 the contribution 
of vasopressin and angiotensin II 
was assessed by comparing 
hemodynamic responses elicited 
by stimulation of NTS A1 
adenosine receptors in intact 
animals with those obtained 
following selective blockade of 
vasopressin V1 receptors and angiotensin II AT1 receptors via iv. injections of selective 
antagonists: [ȕ-mercapto-ȕ,ȕ-cyclopentylmethylenepropionyl,1-O-Me-Tyr2,Arg8]-
vasopressin, (20 ȝg/kg, Sigma)  and losartan (5 mg/kg, Merck Inc.), respectively.  To 
evaluate the potential contribution of circulating norepinephrine to the responses 
ganglionic blockade (hexamethonium bromide, 25 mg/kg iv, Sigma) was combined with 
adrenalectomy (Protocol 3) and these data and the responses observed previously 
Figure 6.  Time line of how experimental protocols are 
executed: vasopressin V1 receptor blockade (VX), lumbar 
sympathectomy + V1 receptor blockade (LX+VX), angiotensin II 
AT1 receptor blockade (ATX), bilateral adrenalectomy + 
ganglionic blockade (ADX+GX), adrenalectomy + ganglionic 
blockade + V1 receptor blockade (ADX+GX+VX) and 
adrenalectomy + ganglionic blockade + V1 receptor blockade + 
AT1 receptor blockade (ADX+GX+VX+ATX).  Time control 
experiments were performed for protocols including ATX and/or 
GX (protocols 2-5) according to the respective diagrams; 
however microinjections of CPA were omitted. 
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following adrenalectomy alone(47) are discussed together.  This indirect evaluation of 
norepinephrine contribution to the responses was necessary because total sympathetic 
denervation is impossible and ganglionic blockade, which prevents secretion of 
norepinephrine from sympathetic terminals, also impairs/abolishes the effects of 
activation of the adrenal medulla; thus ganglionic blockade removes E-adrenergic 
vasodilation simultaneously.  Therefore, the appropriate reference point for the 
responses obtained following the ganglionic blockade (Protocol 3) were the responses 
obtained following adrenalectomy alone which has been already performed in our 
previous study(47).  Protocol 4 removed the combined contribution of norepinephrine and 
vasopressin to the responses (ganglionic blockade + vasopressin V1 receptor blockade) 
whereas Protocol 5 removed the combined effect off all three potential vasoconstrictors 
considered via ganglionic blockade + vasopressin V1 receptor blockade + angiotensin 
AT1 receptor blockade. Protocols 3-5 were performed in adrenalectomized animals to 
clarify the experimental conditions by removing any residual adrenal responses which 
may potentially persist following the ganglionic blockade.  Since preliminary results of 
the above five experimental protocols strongly suggested that only vasopressin has a 
marked contribution to the responses, in Protocol 6 the magnitude of E-adrenergic 
vasodilation alone, not opposed by major vasoconstrictor factors (sympathetic 
vasoconstriction and vasopressin) was assessed. In this protocol bilateral lumbar 
sympathectomy was combined with blockade of V1 vasopressin receptors and these 
data were compared with data following V1 vasopressin receptor blockade alone 
(Protocol 1) and discussed together with previous data obtained following bilateral 
lumbar sympathectomy alone(47).  
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Experimental groups n ¨% Mean Arterial Pressure, mmHg 
¨% Heart Rate, 
beats/min ¨% Iliac Blood Flow 
¨% Iliac vascular 
Conductance 
VX 16 -4.7±1.8# 1.2±0.9 10.2±1.6# 15.3±2.7# 
GX 39 -39.7±1.9# 3.1±1.9 16.6±3.3# 99.9±9.9# 
ATX 15 -49.2±2.8# -13.9±3.5# 8.6±6.1 125.1±18.2# 
 
Table 1.  Maximal hemodynamic responses evoked by blockade of V1 vasopressin receptors (VX), AT1 
angiotensin II receptors (ATX) and ganglionic blockade (GX). 
Data are means r SE.  # P<0.05 vs. zero. Numbers of responses to VX, GX and ATX were combined from those protocols 
where these blockades were applied as a first pharmacological manipulation: nVX = nVX + nLX+VX; nGX = nADX+GX + nADX+GX+VX 
+ nADX+GX+VX+ATX + n of respective controls; nATX = nATX + n of respective control (see Table 2).  The small changes in mean 
arterial pressure and iliac vascular conductance caused by VX were allowed to return spontaneously toward resting levels, 
whereas the large, sustained changes in these variables caused by ATX and GX were compensated via iv infusion of 
phenylephrine (see Table 1). 
 
The effectiveness of vasopressin V1 and angiotensin AT1 receptor blockades 
were tested in separate groups of animals (n=3 for each blockade) with iv injections of 
arginine-vasopressin (50 mU/kg, Sigma) and angiotensin II (300 ng/kg, Sigma), 
respectively, before and after the blockade.  Both blockades remained effective for over 
1 hour.  Blockade of V1 vasopressin receptors caused relatively small decreases in 
MAP and increases in IVC (Table 1) which spontaneously returned toward resting 
values in approximately 10 min; therefore approximately 10 min after V1 
 
Protocol 
number Experimental procedure n 
Infusion rate 
ml/h/kg Time controls n 
Infusion rate 
ml/h/kg 
2 ATX 10 3.18±0.12* ATX 5 2.39±0.25* 
3 ADX + GX 8 3.02±0.24*  ADX + GX 5 3.20±0.33* 
4 ADX + GX + VX 8 3.45±0.41*  ADX + GX + VX 5 3.94±0.62 
5 ADX + GX + VX + ATX  8 6.33±0.24 ADX + GX + VX + ATX 5 5.29±0.62 
 
Data are means r SE.  # P<0.05 vs. zero. Numbers of responses to VX, GX and ATX were combined from those protocols 
where these blockades were applied as a first pharmacological manipulation: nVX = nVX + nLX+VX; nGX = nADX+GX + nADX+GX+VX 
+ nADX+GX+VX+ATX + n of respective controls; nATX = nATX + n of respective control (see Table 2).  The small changes in mean 
arterial pressure and iliac vascular conductance caused by VX were allowed to return spontaneously toward resting levels, 
whereas the large, sustained changes in these variables caused by ATX and GX were compensated via iv infusion of 
phenylephrine (see Table 1). 
 
Table 2. Infusion rates of phenylephrine used to maintain mean arterial pressure and iliac vascular 
conductance at pre-blockade levels in experimental and respective time control groups in which angiotensin 






























Figure 7.  An example of time control experiment following adrenalectomy plus 
ganglionic blockade (GX) plus vasopressin blockade (VX) plus angiotensin II AT1 
receptor blockade (ATX); no CPA was microinjected in this experiment.  The 
dashed arrow denotes  a potential microinjection of CPA and the subsequent 20 
min integration of the response.  Note that although the infusion of phenylephrine 
(PE) did not fully compensated for the decrease in mean arterial pressure (MAP) 
the iliac vascular conductance (IVC) gradually declined constricting iliac 
vasopressinergic blockade the microinjection of CPA was performed in Protocols 1 and 
6 (Figure 6).  However, following blockade of angiotensin AT1 receptors and  ganglionic 
blockade marked and sustained decreases in MAP and increases in IVC were observed 
(Table 1).  Therefore, in Protocols 2-5, where these blockades were performed iv 




blockade values.   
Table 2 presents the 
rates of PE infusion 
needed for the 
compensation.  No 
differences were 
observed in PE 
infusion rates 
between Protocols 2-4.  However, significantly greater PE infusion rates were required 
when angiotensin AT1 receptor antagonists, losartan, were combined with ganglionic 
and V1 vasopressin receptor blockades in Protocol 5 (Table 2).  During the responses to 
stimulation of NTS A1 adenosine receptors PE infusion was continued at the same rates 
as needed to compensate for the altered hemodynamic values in Protocols 2-5. The 
effect of PE infusion on baseline hemodynamic values was estimated in respective time 
controls for Protocols 2-5 (Table 2).  In the time-control experiments all procedures 
except microinjections of CPA were performed in the same time-pattern as in 
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experimental Protocols 2-5.  Figure 7 shows an example of a time control for the most 
complex experimental Protocol 5.  PE infusion rates were similar in the experimental 
protocols and respective time controls (Table 2).   
Vasopressin assay 
Since the hemodynamic experiments (Protocols 1-6) suggested that vasopressin 
plays a dominant role in the iliac vascular responses to stimulation of NTS A1 adenosine 
receptors, in an additional group of animals the effect of microinjections into the NTS of 
CPA (n=8) or respective volume control (50 nl of ACF, n=5) on circulating vasopressin 
were evaluated.  We compared the levels of plasma vasopressin measured 30 min 
before and ~8 min after the microinjections (the average time when maximal 
hemodynamic responses to stimulation of NTS A1 receptors occur).  Arterial blood 
samples (~1 ml) were slowly withdrawn from the femoral artery into prechilled, 
heparinized tubes. Blood volume was kept unchanged via simultaneous infusion of the 
same volume of donor blood into the femoral vein.  The samples were immediately 
placed on ice and centrifuged at 5000 g for 10 min at 4º C. Plasma was collected and 
stored at -70º C.  Plasma vasopressin concentration was assessed via standard 
radioimmunoassay procedures in our laboratory as described previously(32; 54; 61).  The 
sensitivity of the vasopressin assay was 0.1 pg/ml and 50% displacement was 4.1 
pg/tube.  Intra- and inter-assay variability was 7.0% and 13.4%, respectively. 
Data analysis 
Hemodynamic responses were analyzed over a 20 min period following the 
microinjections, similar to our previous study(47).  The responses were quantified as an 
integration of the differences between the baseline and response values averaged in 1 
min periods and summed for 20 min of the response, i.e. when the majority of the 
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responses occur.  The integral reflects the predominant trend of the responses despite 
transient, sometimes large, bidirectional fluctuations in each variable.  Because 
hemodynamic effects evoked by stimulation of NTS A1 adenosine receptors were 
variable, often biphasic, or even polyphasic, as we previously reported(47; 76), we used 
the integral values for the comparison between the experimental groups.  The absolute 
values of blood flow depend to some extent on positioning of the probe around the iliac 
artery; therefore the comparison between the relative changes in MAP, IBF, and IVC 
were more reliable.  The HR responses, calculated from pulse intervals through the flow 
probe, were expressed in absolute values (beats/min).  Iliac vascular conductance (IVC) 
was calculated by dividing iliac blood flow (IBF), expressed as a Doppler shift (in Hz) by 
MAP (in mmHg). In experimental Protocols 2-5, where PE was infused to compensate 
for the decreased MAP and increased IVC the direct effect of PE on baseline 
hemodynamic variables was evaluated in respective time control experiments and 
subtracted from experimental data.  Specifically, changes occurring in each variable 
during time-control experiments were integrated for 20 min and subtracted from the 
respective 20 min integral values obtained in each animal of the experimental groups 
(Protocols 2-5).   
One-way ANOVA for independent measures was used to compare hemodynamic 
responses versus experimental conditions.  Differences observed were further 
evaluated by t-test with Bonferroni adjustment for independent measures. Differences 
between circulating vasopressin levels measured before and after microinjections of 
ACF or CPA were evaluated using paired t-test; the differences in vasopressin levels 
between the groups (ACF vs. CPA) were evaluated using unpaired t-test.  The changes 
in all recorded variables were also compared with zero by means of SYSTAT univariate 
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F test.  An Į level of P < 0.05 was used to determine statistical significance.  
 
RESULTS 
Resting values of MAP, HR, IBF and IVC for each experimental group, measured 
just before stimulation of NTS A1 adenosine receptors, are presented in Table 3.  The 
resting MAP and IVC for all the groups where blockades were performed were not 
different from those for intact animals; this provided reliable comparison between the 
experimental protocols.  The direct effects of ganglionic blockade, and blockade of V1 
vasopressin and AT1 angiotensin II receptors on all hemodynamic variables are 
presented in Table 1.  The large decreases in MAP and increases in IVC evoked by 
blockade of AT1 angiotensin II receptors and/or ganglionic blockade required additional 
compensation with PE, whereas the small decreases in MAP and increases in IVC 
evoked by V1 vasopressin receptor blockade were allowed to partially recover without 
compensation.    
 
Protocol 










 INTACT 13 98.1±.1 353.9±4.7 1030.2±3.6 10.9±3.3 
1 VX 8 105.3±4.9 359.7±11.2 1091.0±204.2 10.6±2.0  
2 ATX 10 95.3±4.9 342.2±8.2 992.8±122.5 10.8±1.5 
3 ADX + GX 8 93.1±5.1 383.6±11.4 1190.4±167.2 13.2±2.1  
4 ADX + GX + VX 8 88.7±1.3 383.3±9.0 1394.0±222.7 15.8±2.7  
5 ADX + GX + VX + ATX  8 88.1±2.1 405.0±10.9* 1271.0±102.9 14.4±1.1 
6 LX + VX 8 95.8±4.1 340.6±7.0 1336.4±132.8* 14.3±1.7  
(2) Control  
(ATX) 5 99.3±2.8 330.0±11.8 973.7±173.2 10.0±2.0 
(3) Control  
(ADX + GX) 5 84.2±2.8 365.8±17.2 1073.1±144.7 12.8±1.8  
(4) Control  
(ADX + GX + VX) 5 88.1±3.5 381.6±7.8 1121.6±141.1 12.7±1.4  
(5) Control  
(ADX + GX + VX + ATX) 5 90.2±4.7 398.9±13.3 1144.6±302.0 12.2±2.4  
Table 3.  Resting values of hemodynamic parameters in each experimental group. 
Data are means r SE; n=number of rats.  Numbers in parentheses show time controls for respective protocols. 
Resting values for intact animals and following: vasopressin V1 receptor blockade (VX), angiotensin II AT1 receptor 
blockade (ATX), bilateral adrenalectomy + ganglionic blockade  (ADX+GX), adrenalectomy + ganglionic blockade 
+ V1 receptor blockade (ADX+GX+VX), adrenalectomy + ganglionic blockade + V1 receptor blockade + AT1 




Effects of V1, AT1 and ganglionic blockades on responses to stimulation of NTS A1 
adenosine receptors 
Figure 8 presents examples of the responses evoked by selective stimulation of 
NTS A1 adenosine receptors which were observed most often under each experimental 





















































TIME (min) TIME (min) TIME (min) TIME (min)TIME (min) TIME (min)
CPA CPA CPA CPA CPA 
Figure 8.  Mean arterial pressure (MAP), iliac blood flow  (IBF) and iliac vascular conductance (IVC) 
responses to microinjection of adenosine A1 receptor agonist (CPA, 330 pmol/50 nl) into the 
subpostremal NTS in intact rats (INT) and following: vasopressin V1 receptor blockade (VX), 
angiotensin II AT1 receptor blockade (ATX), bilateral adrenalectomy + ganglionic blockade  
(ADX+GX), adrenalectomy + ganglionic blockade + V1 vasopressin receptor blockade 
(ADX+GX+VX) and adrenalectomy + ganglionic blockade + V1 vasopressin receptor blockade + AT1 
angiotensin II receptor blockade (ADX+GX+VX+ATX).  Microinjections of CPA, marked by vertical 
arrows, were applied ~10 -20 min after the blockades, when baseline levels of all variables stabilized 
(see Figure 6).  Note that VX reversed pressor and vasoconstrictor responses most often observed 
in INT group into depressor and vasodilatory responses.   ADX+GX exaggerated the pressor and 
vasoconstrictor response. These exaggerated vasoconstrictor responses were virtually abolished 


































































# P<0.05 vs. Zero
* P<0.05 vs. INT
#
Figure 9.  Integral responses of MAP, IBF and IVC 
evoked by microinjections of CPA (330 pmol /50 nl) 
into the caudal subpostremal NTS.  Abbreviations 
as in Figure 8.  Data are means ± SE.  In groups 
ATX, ADX+GX, ADX+GX+VX, ADX+GX+VX+ATX 
respective time control values were subtracted. *, 
different versus intact group (P<0.05).  #, different 
versus zero (P<0.05).  VX reversed iliac 
vasoconstrictor responses observed in intact group 
into vasodilation and virtually abolished exaggerated 
vasoconstrictor responses observed following 
ADX+GX.
Protocol 










   Incr Decr Incr Decr Incr Decr Incr Decr 
 INTACT 13 10 3 1 12 1 12 1 12 
1 VX 8 0 8 0 8 3 5 7 1 
2 ATX 10 9 1 4 6 2 8 0 10 
3 ADX + GX 8 8 0 1 7 0 8 0 8 
4 ADX + GX + VX 8 5 3 2 6 0 8 1 7 
5 ADX + GX + VX + ATX 8 7 1 2 6 1 7 0 8 
6 LX + VX 8 1 7 1 7 5 3 8 0 
 
Table 4.  Number of individual experiments where overall increments or decrements were observed for 
each recorded hemodynamic parameter based on its integral values 
Number of increments (Incr) and decrements (Decr) observed in intact animals and following: vasopressin V1 
receptor blockade (VX), angiotensin II AT1 receptor blockade (ATX), bilateral adrenalectomy + ganglionic blockade  
(ADX+GX), adrenalectomy + ganglionic blockade + V1 receptor blockade (ADX+GX+VX), adrenalectomy + 
ganglionic blockade + V1 receptor blockade + AT1 receptor blockade (ADX+GX+VX+ATX), and lumbar 
sympathectomy + V1 receptor blockade (LX+VX).
in Figure 9.  In intact animals the typical 
variability in the responses to stimulation of 
NTS A1 adenosine receptors was observed: 
the pressor and vasoconstrictor responses  
prevailed (Table 4, Figures 8 and 9), 
although biphasic, polyphasic or, more 
rarely, depressor and vasodilatory 
responses were also observed.  As we 
previously demonstrated, these patterns and 
variability of the responses reflected 
counteracting effects of E-adrenergic 
vasodilation vs. sympathetic and humoral 
vasoconstriction(47; 76).  V1 vasopressin 
receptor blockade reversed iliac 
vasoconstrictor responses observed in the 
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intact group into slight iliac vasodilation (P=0.0001 vs. intact).  Blockade of angiotensin 
II AT1 receptors alone did not significantly alter the responses in comparison to the 
intact group (P>0.05 for all variables).  Elimination of adrenal and sympathetic neural 
effects on the iliac vasculature (Protocol 3) increased the iliac vasoconstrictor 
responses almost 4-fold in comparison to the intact group indicating that other humoral 
factor(s) different than circulating norepinephrine play a crucial role in the iliac 
vasoconstrictor responses.  Subsequent blockade of vasopressin V1 receptors (Protocol 
4) virtually abolished the exaggerated iliac vasoconstriction observed following 
adrenalectomy plus ganglionic blockade alone (Protocol 3) (Figures 8 and 9) indicating 
that the humoral iliac vasoconstriction evoked by stimulation of NTS A1 adenosine 
receptors is mediated mostly via the release of vasopressin.  Combined blockade of 
neural and all considered humoral factors (adrenalectomy + ganglionic + V1 
vasopressinergic + AT1 angiotensinergic blockades, Protocol 5) had very similar effects 
on the responses to that observed in Protocol 4 (adrenalectomy + ganglionic + V1 
vasopressinergic blockades); there were no significant differences between these two 
groups with respect to MAP, HR and IVC responses (P>0.05 for all comparisons).   The 
lack of differences between responses observed in Protocols 4 and 5 additionally 
confirmed that vasopressin is the dominant humoral vasoconstrictor factor triggered by 
stimulation of NTS A1 adenosine receptors.  The analysis of absolute values of the 
integral responses presented in Table 5 leads to the same conclusions as those based 
on the relative responses (Figure 9).  The absolute values of the responses, presented 
in Table 5, show residual iliac vasoconstrictor effects in Protocols 4 and 5.  However, 
this vasoconstriction was abolished when the respective time control values were 




Data collected in Protocols 1-5 (Figures 4 and 5) strongly suggested that the only 
significant humoral vasoconstrictor contributing to iliac vascular responses evoked by 
selective stimulation of NTS A1 adenosine receptors is vasopressin. Therefore, in 
Protocol 6 vasopressin and lumbar sympathetic vasoconstrictor components of the 
responses were eliminated to unmask E-adrenergic vasodilation alone, not opposed by 
neural and humoral vasoconstriction.  Following V1 vasopressin receptor blockade 
combined with bilateral lumbar sympathectomy (Protocol 6) the iliac vasodilation 
response doubled in comparison to that observed following V1 vasopressin receptor 
blockade alone (405.1± 58.4³'% vs. 195.8±51.2³'%, P=0.0175).  
The above observations are supported by comparison of the frequency of which 
we observed increases vs. decreases in hemodynamic variables in each experiment for 
all experimental groups (Table 4).  In intact animals, decreases in IVC prevailed 
Protocol 










 INTACT 13 86.0±37.7# -379.3±96.4# -1480.3±588.7# -23.1±7.1# 
1 VX 8 -195.2±63.9*# -411.9±99.3# 59.6±784.5 20.8±9.3*# 
2 ATX 10 198.4±47.3# -70.6±126.0 -1585.8±445.4# -34.8±6.4# 
3 ADX + GX 8 312.3±67.1*# -139.0±48.6# -5758.2±1284.4*# -91.6±20.2*# 
4 ADX + GX + VX 8 7.1±46.3 -237.0±137.5 -2752.3±715.7# -31.3±11.5# 
5 ADX + GX + VX + ATX  8 74.9±19.0# -249.8±134.8 -1784.9±447.1# -30.9±5.5# 
6 LX + VX 8 -162.0±71.5*# -502.0±177.3# 2127.6±1489.5* 57.5±11.4*# 
(2) Control 
(ATX) 5 80.0±37.6 504.1±91.8*
# -303.2±573.6 -9.8±3.6# 
(3) Control 
(ADX + GX) 5 22.3±36.2 54.5±104.8* -166.1±364.4 -5.9±3.8 
(4) Control 
(ADX + GX + VX) 5 15.6±39.7 163.3±54.5*
# -1224.1±380.7# -13.8±5.1# 
(5) Control 
(ADX + GX + VX + ATX) 5 -11.4±23.7 206.5±61.6*
# -2694.9±1428.2 -24.7±13.0 
 
Table 5.  Absolute values of integral changes in MAP, HR, IBF and IVC evoked by microinjections of CPA (330 
pmol in 50 nl) into the NTS in each experimental group. 
Data are means r SE.   * P<0.05 vs. Intact; # P<0.05 vs. zero.  Numbers in parentheses show time controls for respective 
protocols.  Integral changes for intact animals and following: vasopressin V1 receptor blockade (VX), angiotensin II AT1 receptor 
blockade (ATX), bilateral adrenalectomy + ganglionic blockade  (ADX+GX), adrenalectomy + ganglionic blockade + V1 receptor 
blockade (ADX+GX+VX),  adrenalectomy + ganglionic blockade + V1 receptor blockade + AT1 receptor blockade 
(ADX+GX+VX+ATX), and lumbar sympathectomy + V1 receptor blockade (LX+VX). 
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whereas following V1 vasopressinergic blockade the increases in IVC prevailed. 
Combined V1 vasopressinergic blockade and lumbar sympathectomy completely 
eliminated iliac vasoconstrictor responses (Protocol 6).   AT1 angiotensinergic blockade 
increased the number of pressor and vasoconstrictor events in comparison to the INT 
group (Table 4), although there were no significant differences between the averaged 
responses observed in this vs. intact groups (Figure 9). Adrenalectomy plus ganglionic 
blockade completely eliminated the depressor and iliac vasodilatory responses as 
expected (Protocol 3).  When V1 vasopressinergic blockade was added to 
adrenalectomy and ganglionic blockade (Protocol 4) or all the blockades were 
performed in adrenalectomized animals (Protocol 5) again variable 
vasoconstrictor/vasodilatory responses were observed; however, this variability 
reflected rather random variations of IVC as vascular responses were virtually abolished 
in these groups (changes in IVC were not different from zero, Figure 9).  Prevailing 
pressor and depressor responses were consistent with prevailing vasoconstrictor and 
vasodilatory responses in each experimental group.  However, the decreases in HR 
dominated in all experimental groups despite the different experimental conditions.  
Release of vasopressin in response to stimulation of NTS A1 adenosine receptors 
The above results, obtained via pharmacological blockade approaches, strongly 
suggested that vasopressin is a dominant vasoconstrictor factor released into the 
circulation following the selective stimulation of NTS A1 adenosine receptors.  
Therefore, in an additional two groups of animals we tested this hypothesis more 
directly by measuring whether the plasma levels of vasopressin indeed increase as a 
result of stimulation of NTS A1 adenosine receptors (Figure 10).  The resting levels of 
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Figure 10. Comparison of plasma vasopressin levels measured 
before (Pre) and after (Post) microinjections into the NTS of vehicle 
(ACF, n=5) or selective A1 adenosine receptor agonist (CPA, n=8).  
*, differences between pre- vs. post-microinjections (P<0.05); #, 
differences between the groups (P<0.05). CPA increased 
circulating vasopressin levels 4-fold whereas ACF did not 
significantly increase the level of circulating vasopressin.
in comparison to vasopressin 
levels normally observed in 
intact conscious animals(12; 32; 
35; 53; 54) consistent with levels 
associated with anesthesia 
and surgical stress(12; 35).  
Stimulation of NTS A1 
adenosine receptors increased 
circulating vasopressin levels 
over 4-fold (P=0.0006).  
Microinjection of ACF into the 
NTS also tended to increase the level of circulating vasopressin; however the increase 
did not reach statistical significance (P=0.083).  Notably the difference between 
vasopressin levels measured across the groups, i.e. following microinjections of CPA 
vs. ACF was also significant (P=0.041). 
DISCUSSION  
The present study assessed the relative roles of three major humoral 
vasoconstricting factors in mediating the responses to stimulation of A1 adenosine 
receptors located in the NTS. The release of humoral vasoconstrictor factor(s) had been 
implied by our previous study which showed that the large iliac vasoconstriction, 
triggered by stimulation of NTS A1 adenosine receptors, persisted after bilateral lumbar 
sympathectomy and adrenalectomy(47).  The major finding of the present study is that 
vasopressin is released into the circulation upon stimulation of NTS A1 adenosine 
receptors and that it is the primary humoral factor contributing to the iliac 
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vasoconstriction.  The potential release of norepinephrine and angiotensin II did not 
contribute significantly to the iliac vascular responses. 
NTS A1 adenosine receptors are involved in control of vasopressin release  
Our previous studies strongly suggested that A1 adenosine receptors may 
modulate vasopressin release at the level of the NTS similarly as they modulate 
baroreflex control of regional sympathetic outputs and HR(71; 76). However, considering 
differential localization/expression of adenosine receptor subtypes on functionally 
different NTS neurons(72; 77), it remained unknown if A1 adenosine receptors are indeed 
located on these baroreflex neurons controlling vasopressin release.  The present study 
showed that activation of A1 adenosine receptors in the NTS disinhibits vasopressin 
release. Therefore, pre- and/or postsynaptic A1 adenosine receptors are likely located 
on those NTS baroreflex neurons/terminals which control vasopressin release. This 
hypothesis based on integrative, systemic data may be confirmed in future studies at 
the cellular level.  
The most likely mechanism responsible for the release of vasopressin into the 
circulation in response to stimulation of NTS A1 adenosine receptors is the inhibition of 
baroreflex transmission in the NTS resulting in the disinhibition of vasopressin release 
from hypothalamic nuclei (paraventricular and supraoptic)(20).  The role of NTS in 
baroreflex control of vasopressin release has been well established(66; 83). Bilateral 
inhibition, anesthetization or lesioning of the NTS, which removes baroreflex 
mechanisms, results in 10-fold increases of circulating vasopressin levels and 
vasopressin-mediated hypertension(83).  Sinoaortic baroreceptor denervation prevents 
this response(66).  In the present study the unilateral inhibition of NTS baroreflex 
mechanisms via unilateral activation of A1 adenosine receptors resulted in 5-fold 
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increases in circulating vasopressin.  
Relative roles of vasoactive factors triggered by activation of A1 adenosine receptors in 
the NTS 
Our previous study showed that activation of A1 adenosine receptors in the NTS 
evokes neural and humoral iliac vasoconstriction opposed by E-adrenergic 
vasodilation(47).  The counteracting vascular effects contributed to the variability of the 
overall pressor/depressor responses with prevailing vasoconstriction and increases in 
MAP.  These conclusions were based on comparison of iliac vascular responses 
observed in intact animals and following E-adrenergic blockade, bilateral 
adrenalectomy, lumbar sympathectomy and combined adrenalectomy plus lumbar 
sympathectomy.  The present study investigated potential humoral vasoconstrictors 
(vasopressin, angiotensin II and norepinephrine) by assessing the effects of 
vasopressin V1 receptor and angiotensin AT1 receptor blockade as well as ganglionic 
blockade performed in adrenalectomized animals.  Perhaps the most compelling results 
were that the blockade of peripheral V1 vasopressin receptors reversed the normal iliac 
vasoconstriction into marked vasodilation. This vasodilation was further enhanced by 
adding lumbar sympathectomy to the V1 receptor blockade.  It is likely that sympathetic 
nerves have a smaller role than vasopressin in mediating this iliac vasoconstriction as 
lumbar sympathectomy alone, performed in our previous study(47), had a relatively 
smaller effect on the IVC responses then V1 vasopressinergic blockade alone, 
performed in the present study.  Collectively, these data indicate that vasopressin alone 
can override epinephrine induced iliac vasodilation and induce vasoconstriction, but that 
sympathetic nerves alone do not.  The roles of vasopressin and sympathetic nerves 
appear additive as the sum of the individual effects approximate that of the combined 
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effects.  Vasopressin together with increases in LSNA can induce significant 
vasoconstriction without which a powerful E adrenergic vasodilation is revealed.  We 
conclude that the variability often seen in the arterial pressure response to A1 receptor 
stimulation is the direct result of these “push-pull” counteracting mechanisms.   
Circulating norepinephrine potentially released upon stimulation of NTS A1 
adenosine receptors likely has little role as ganglionic blockade did not lessen the 
intense iliac vasoconstriction seen after bilateral adrenalectomy(47).  Probably the 
amount of norepinephrine released from sympathetic terminals was too small to exert 
measureable effects beyond that of circulating norepinephrine already likely to be 
elevated as a result of anesthesia and surgical stress.  A previous study from our 
laboratory showed that pre-ASNA increased much more than RSNA and LSNA in 
response to stimulation of NTS A1 adenosine receptors(76).  It is possible that other 
sympathetic outputs responded even less or might even be inhibited with the 
stimulation.  This could cause the increase of circulating norepinephrine in the present 
study to be functionally irrelevant.   
Angiotensin II blockade alone markedly decreased baseline MAP and increased 
IVC.  However the normal pressor and vasoconstrictor responses to microinjections of 
CPA did not decrease but rather tended to increase.  This indicates that angiotensin II, 
similarly as circulating norepinephrine, does not contribute to the iliac vasoconstriction 
elicited by stimulation of NTS A1 adenosine receptors.  Although increases of RSNA 
may cause an increase in the release of renin from the kidney(23), the total time from 
activation of the renal nerve to the subsequent release of renin and conversion of 
angiotensinogen to angiotensin I and then to angiotensin II may have exceeded the time 
of the analyzed responses.  In addition, losartan used to block AT1 receptors in this 
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study most likely crossed the blood-brain barrier and might evoke central effects 
counteracting the peripheral actions. Nevertheless, our data show that circulating 
angiotensin II had no functional effect as a potential humoral iliac vasoconstrictor 
triggered by stimulation of NTS A1 adenosine receptors. 
Vasoactive effects of NTS A1 vs. A2a adenosine receptor subtypes 
The predominately pressor but often variable responses to selective stimulation 
of NTS A1 adenosine receptors are mediated most likely via inhibition of baroreflex 
glutamatergic transmission in the NTS and resetting of baroreflex functions toward 
higher MAP(71; 76).  In contrast, selective stimulation of NTS A2a adenosine receptors 
evokes decreases in MAP and preferential iliac vasodilation mediated via non-
baroreflex, nonglutamatergic mechanism(s)(37; 74; 75).  These responses were mediated 
mostly via activation of the adrenal medulla and E-adrenergic mechanism and to a 
lesser extent via lumbar sympathetic nerves(42).  However, no other humoral 
mechanisms were involved as bilateral adrenalectomy and lumbar sympathectomy 
abolished the responses(42).  How do these two adenosine receptor subtypes contribute 
to the responses mediated by adenosine operating in the NTS under physiological(19; 82) 
or pathological(56; 78; 89; 92) conditions?  It is well known that microinjections of adenosine 
into the NTS results in depressor responses similar to those observed following 
selective activation of A2a adenosine receptors(6; 51; 85).  However, both adenosine 
receptor subtypes may contribute to the depressor responses as they both activate the 
adrenal medulla and facilitate E-adrenergic vasodilation via baroreflex and unknown, 
non-baroreflex mechanisms(74; 76).  Other components of the responses elicited by NTS 
A2a receptors (decreases in RSNA and HR) may further contribute to the depressor 
responses, whereas A1 receptor-mediated sympathoactivation and vasopressin release 
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would oppose these responses.   Under physiological conditions adenosine may 
contribute to the pressor effects evoked by stimulation of the hypothalamic defense 
area(19; 82) via A1 receptor-mediated inhibition of baroreflex mechanisms and resulting 
sympathoactivation and vasopressin release(71; 76).  In contrast, under pathological 
conditions naturally released adenosine, acting via both A1 and A2a adenosine receptor 
subtypes, may contribute to the paradoxical sympathoinhibition and cardiac slowing 
observed during hypovolemic phase of hemorrhagic shock(78).  
Limitations of the method 
In the central nervous system adenosine is not released synaptically, but rather 
produced in the extracellular space via the degradation of ATP which is released at 
synaptic terminals from neurons as well as released from glial cells activated by 
extracellular glutamate diffused from nearby active nerve terminals(9; 13; 33; 94). In 
addition, under pathological conditions adenosine is released into the extracellular 
space in a global, non-synaptic manner from hypoxic/hypoperfused neurons and glial 
cells(56; 56; 89; 92).  Therefore the natural, spatial (not strictly synaptic) action of adenosine 
in the NTS, may be simulated well via microinjections of selective agonists of adenosine 
receptor subtypes.  Importantly, although adenosine is released non-selectively in the 
NTS, it does produce specific differential responses in regional sympathetic outputs and 
vascular beds as shown by numerous studies from our laboratory(7; 71; 73-76).  We believe 
that these specific, differential effects evoked by nonspecific, spatial activation of 
adenosine receptors result from differential location/expression of adenosine receptor 
subtypes on NTS neurons and synaptic terminals controlling different sympathetic 
outputs and involved in different mechanisms integrated in the NTS(72; 77).  To confirm 
this hypothesis, based on systemic, integrative approaches, further studies at the 
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cellular level are required. 
The experiments were performed in anesthetized animals and these conditions 
most likely attenuated baroreflex mechanisms which may have contributed to the 
increased vasopressin levels.  In the conscious rat circulating vasopressin level is ~ 2 
pg/ml(12; 32; 35; 53; 54; 61).  With even limited surgery under anesthesia baseline vasopressin 
rises to ~6-10 pg/ml(12; 35; 66; 83). In our study after extensive surgery under anesthesia 
baseline vasopressin levels were ~25 pg/ml.  However, despite the increased baseline 
vasopressin levels, activation of NTS A1 adenosine receptors triggered marked release 
of vasopressin into the circulation (Figure 10) and a powerful V1 receptor mediated 
vasoconstrictor effect in the hindlimb vasculature was apparent (Figure 9).  In contrast, 
no functional effects of potential, A1-adenosine-receptor-mediated increases in 
circulating norepinephrine or angiotensin II were observed. 
Glucocorticoid deficiency, which may be observed following chronic 
adrenalectomy, increases circulating levels of vasopressin(41).  However, this effect 
seems to be mediated at the level of transcription of the vasopressin gene and not an 
immediate release(41).  Therefore, in the animals in which the adrenal glands were 
removed acutely, as in the present study, increased resting levels of vasopressin were 
most likely due to anesthesia and surgical stress. 
The large and sustained changes in resting hemodynamic variables following 
AT1 angiotensinergic and ganglionic blockades required compensation with iv infusions 
of phenylephrine to make the relative responses comparable across the experimental 
groups.  It was extremely difficult to return both MAP and IVC to the pre-blockade 
levels.  Since we tried to compensate most accurately for IVC, the resting MAP, 
preceding the microinjections into the NTS in the groups where ganglionic blockade was 
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combined with V1 vasopressinergic and with AT1 angiotensinergic blockades (Protocols 
4 and 5), was slightly lower in comparison to other experimental groups. The long 
lasting compensatory infusions of phenylephrine in Protocols 2-5 could facilitate central 
baroreflex mechanisms(38). Therefore, the inhibition of enhanced baroreflex activity via 
stimulation of NTS A1 adenosine receptors could result in relatively greater pressor and 
vasoconstrictor responses compared to those observed in intact animals and following 
V1 vasopressinergic blockade alone (Protocol 1) and V1 vasopressinergic blockade 
combined with lumbar sympathectomy (Protocol 6). In fact, pressor and vasoconstrictor 
responses tended to increase following AT1 receptor blockade although this tendency 
did not reach statistical significance.  The pressor and vasoconstrictor responses 
observed after adrenalectomy combined with ganglionic blockade (Protocol 3) were not 
different from those observed following adrenalectomy alone in our previous study(47). 
Finally, these responses (even if slightly exaggerated) were virtually abolished by the 
vasopressinergic blockade (Protocols 4 and 5). Therefore, the potential central effects 
of infusions of phenylephrine on responses to stimulation of NTS A1 adenosine 
receptors were likely negligible and did not affect the primary conclusions of the present 
study.  The infused phenylephrine activated D1 adrenergic receptors located on vascular 
smooth muscles, including those in the iliac vascular bed.  The occupation of D1 
adrenergic receptors by an exogenous agonist could mask the effect of circulating 
endogenous norepinephrine which may be potentially increased following stimulation of 
NTS A1 adenosine receptors.  The peripheral interactions between simultaneously 
activated V1, D1 and AT1 receptors could further complicate the comparison of relative 
roles of humoral vasoconstrictor factors obscuring the smaller ones. Nevertheless, the 
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marked effects of vasopressin V1 receptor blockade were evident in experimental 
groups with and without phenylephrine compensation (Protocols 1 and 6 vs. Protocols 4 
and 5).  This indicates that vasopressin contribution to the iliac vasoconstriction was 
much larger than the contribution (if any) of other potential vasoconstrictors 
(norepinephrine and/or angiotensin II). 
Conclusion 
Selective stimulation of NTS A1 adenosine receptors triggers the release of 
vasopressin into the circulation, strongly suggesting that A1 adenosine receptors are 
likely located on afferent terminals and/or NTS interneurons mediating baroreflex control 
of vasopressin release.  Vasopressin is a major humoral vasoconstrictor factor 
contributing to the iliac vascular responses.  The natural variability of MAP and IVC 
responses to stimulation of NTS A1 adenosine receptors observed in intact animals is a 
result of the simultaneous triggering of sympathetic and vasopressinergic 
vasoconstriction counteracted by E-adrenergic vasodilation resulting mainly via 





Activation of NTS A1 adenosine receptors provides differential neural and 
humoral control of regional vascular beds 
ABSTRACT  
 Our previous studies showed that stimulation of adenosine A1 receptors located 
in the nucleus of the solitary tract (NTS) exerts counteracting effects on the iliac 
vascular bed: activation of the adrenal medulla and ȕ-adrenergic vasodilation versus 
sympathetic and vasopressinergic vasoconstriction.  Since NTS A1 adenosine receptors 
inhibit baroreflex transmission in the NTS and contribute to the pressor component of 
the hypothalamic defense response, we hypothesized that these receptors also 
contribute to the redistribution of blood from the visceral to the muscle vasculature via 
prevailing sympathetic and vasopressinergic vasoconstriction in the visceral (renal and 
mesenteric) vascular beds and prevailing E-adrenergic vasodilation in the somatic (iliac) 
vasculature. To test this hypothesis we compared the A1 adenosine-receptor-mediated 
effects of each vasoactive factor triggered by NTS A1 adenosine receptor stimulation 
(N6-cyclopentyladenosine, CPA, 330 pmol in 50 nl) on the regional vascular responses 
in urethane/chloralose anesthetized rats. The single factor effects were separated using 
adrenalectomy, E-adrenergic blockade, V1 vasopressinergic blockade and sinoaortic 
denervation.  In intact animals initial vasodilation was followed by large, sustained 
vasoconstriction with smaller responses observed in renal vs. mesenteric and iliac 
vascular beds.   The initial E-adrenergic vasodilation prevailed in the iliac vs. mesenteric 
and renal vasculature.  The large and sustained vasopressinergic vasoconstriction was 
similar in all vascular beds.  Small sympathetic vasoconstriction was observed only in 
the iliac vasculature in this setting.  We conclude that although A1 adenosine-receptor-
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mediated E-adrenergic vasodilation may contribute to the redistribution of blood from the 
visceral to the muscle vasculature, this effect is overridden by sympathetic and 
vasopressinergic vasoconstriction. 
INTRODUCTION 
Recent studies have firmly established that adenosine operating as a 
neuromodulator in the nucleus of the solitary tract (NTS) modifies cardiovascular control 
(30; 37; 47; 48; 71; 77; 78; 80-82).  The NTS is a major integrative center for visceral and 
autonomic reflexes and contains the greatest density of adenosine uptake sites within 
the central nervous system (11).  Adenosine operates in the NTS in both physiological 
and pathological situations.  Under normal, physiological conditions a natural source of 
adenosine is  ATP released from neurons and glial cells(13).  This occurs, for example 
during the stress or hypothalamic defense response(80-82).  Extracellular ATP is 
catabolized via ectonucleotidases to adenosine which acts globally on pre or post-
synaptic A1 or A2a adenosine receptors located in the NTS(13; 94).  Adenosine is also 
released under pathological conditions such as ischemia, hypoxia and severe 
hemorrhage via the breakdown of intracellular ATP(56; 89; 92).  Therefore, adenosine is an 
important neuromodulator helping to regain homeostasis in these life threatening 
situations via specific modulation of central mechanisms of cardiovascular control.  
Although adenosine is released globally, it may however, differentially modulate 
autonomic reflexes integrated in the NTS(37; 71). The differential action of adenosine is 
most likely due to differential localization of adenosine receptor subtypes on NTS 
terminals/interneurons involved in different reflexes which finally target different 
sympathetic outputs and vascular beds as we suggested previously(72; 77). 
 Adenosine may either inhibit or facilitate neurotransmission via A1 or A2a 
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receptors, respectively.  Selective stimulation of A1 versus A2a receptors often, but not 
always, exerts counteracting hemodynamic effects.  Stimulation of A1 adenosine 
receptors in the NTS yields predominately pressor and vasoconstrictor effects in the 
hindlimb accompanied with differential regional sympathoactivation 
(adrenal>renallumbar)(76).  In contrast, NTS A2a adenosine receptor stimulation yields 
depressor responses, decreases in renal sympathetic nerve activity (RSNA), no 
changes in lumbar sympathetic nerve activity (LSNA) and activation of pre-ganglionic 
adrenal sympathetic nerve activity (pre-ASNA)(73; 74).  Interestingly, both receptor 
subtypes preferentially activate the adrenal medulla.  We have previously shown that 
both A1 and A2a adenosine receptors evoke E-adrenergic vasodilation in the iliac 
vascular bed, as E-adrenergic receptors are predominantly located in the skeletal 
muscle vasculature(90).  However, stimulation of A1 adenosine receptors alone in the 
NTS often yields variable responses, although predominantly pressor and iliac 
vasoconstrictor responses prevail(76).  Recent studies have attributed this variability to 
the activation of the adrenal medulla, the subsequent release of epinephrine eliciting 
activation of E-adrenergic vasodilation which is simultaneously opposed by sympathetic 
and vasopressinergic vasoconstriction(47; 48).  The increased vasoconstrictor drive and 
simultaneously triggered E-adrenergic vasodilation were most likely mediated via 
inhibition of NTS baroreflex mechanisms(68; 71; 76).   
 Stimulation of NTS A1 adenosine receptors differentially affects baroreflex control 
and baseline levels of regional sympathetic outputs, and baroreflex control of vascular 
beds is regionally different(25; 64; 71).  Furthermore, there is differential regional 
distribution of D1 and E2-adrenergic receptors(36; 90) as well as differential reactivity of 
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regional vascular beds to vasopressin and D1-adrenergic activation(28; 29; 34; 45).  
Therefore it was likely that the contribution of vasoconstrictor and vasodilatory effects 
may be different between somatic (iliac) vs. visceral vascular beds (mesenteric and 
renal).  In support of this hypothesis it has been shown that adenosine, operating mostly 
via A1 receptors located in the NTS and rostral ventrolateral medulla, participates in the 
pressor component of the hypothalamic defense response(80-82) and may possibly 
contribute to the redistribution of blood flow from the viscera to skeletal muscle which is 
a key element of this response(93).  We hypothesized that NTS A1 adenosine receptor 
induced sympathetic and vasopressinergic vasoconstriction would prevail over E-
adrenergic vasodilation to a greater extent in the visceral vascular beds compared to 
muscle.  To address this hypothesis we compared the simultaneously recorded vascular 
responses of iliac, mesenteric and renal vascular beds evoked by selective activation of 
NTS A1 adenosine receptors in intact animals and after selective elimination of each 
major vasodilating and vasoconstricting factor. 
MATERIALS AND METHODS 
All protocols and surgical procedures employed in this study were reviewed and 
approved by the institutional Animal Care and Use Committee and were performed in 
accordance with the Guiding Principles in the Care and Use of Animals endorsed by the 
American Physiological Society and published by the National Institutes of Health. 
Design 
 The relative contribution of three neural and humoral vasoactive factors 
(sympathetic and vasopressinergic vasoconstriction opposed by E-adrenergic 
vasodilation) to the regional vascular responses evoked by selective stimulation of NTS 
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A1 adenosine receptors were studied in 53 male Sprague Dawley rats.  The relative 
changes in iliac (IVC), mesenteric (MVC) and renal (RVC) vascular conductance 
evoked by microinjections into the NTS by the selective A1 adenosine receptor agonist 
N6-cyclopentyladenosine (CPA, Tocris) observed in intact animals (n=8) were compared 
with the responses evoked after the following six experimental procedures:   
Protocol 1, bilateral adrenalectomy  (ADX, n=8)   
Protocol 2, blockade of E-adrenergic receptors (EX, n=7)   
Protocol 3, selective vasopressin V1 receptor blockade (VX, n=7)   
Protocol 4, sinoaortic denervation (SAD, n=7)  
Protocol 5, bilateral adrenalectomy combined with selective vasopressin V1 receptor 
blockade (ADX+VX, n=8)   
Protocol 6, sinoaortic denervation combined with bilateral adrenalectomy (SAD+ADX, 
n=8).    
 Blockade of E-adrenergic receptors was performed as in our previous studies via 
injection of propranolol (2 mg/kg i.v.)(42; 47).  Vasopressin V1 receptors, mediating 
vascular constriction, were blocked by i.v. injections of [ȕ-Mercapto-ȕ,ȕ-
cyclopentylmethylenepropionyl,1-O-Me-Tyr,2Arg8]-Vasopressin, selective V1 
antagonist, (20 ȝg/kg, Sigma) in doses which completely blocked vasoconstriction 
evoked by i.v. injection of vasopressin (50 mU/kg, Sigma).  The blockades were applied  
~10 min before the microinjection into the NTS(47; 48).  Sinoaortic denervation was 
accomplished at the beginning of surgery, as described previously(69; 76).  The 
completeness of the denervation was tested ~2 hr later before the start of the protocol.  
The procedure was considered complete if intravenous phenylephrine-induced 
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increases in MAP > 30 mmHg did not decrease HR more than 5 beats/min. 
Instrumentation and measurements 
 All procedures were described in detail previously(7; 42; 47; 48; 68; 74-76).  Briefly, male 
Sprague-Dawley rats (350-400 g, Charles River) were anesthetized with a mixture of Į-
chloralose (80 mg/kg) and urethane (500 mg/kg) i.p., tracheotomized, connected to a 
small animal respirator (SAR-830, CWE, Ardmore, PA) and artificially ventilated with 
40% oxygen 60% nitrogen mixture. Catheterizations of the right femoral artery and vein 
were performed to monitor arterial blood pressure and infuse drugs. Arterial blood 
gases were tested occasionally for appropriate experimental values (Radiometer, 
ABL500, OSM3).  Averaged values measured at the end of each experiment were the 
following:  pH =7.37±0.01, Po2 =144.2±5.0 mmHg, and Pco2 = 36.2±0.9 mmHg.    
 From a mid-abdominal incision, the left iliac artery, superior mesenteric artery 
and the left renal artery were exposed.  Pulsed Doppler blood flow velocity transducers 
(Baylor Electronics) were placed around the arteries and connected to the flowmeter.  
From the same mid-abdominal incision, in some animals, bilateral adrenalectomy was 
performed.  
Arterial blood pressure and iliac, mesenteric and renal and flow signals were 
digitized and recorded with an analog-digital converter (Modular Instruments) interfaced 
to a laboratory computer.  The signals were recorded continuously using Biowindows 
software (Modular Instruments), averaged over 5 second intervals and stored on hard 
disk for subsequent analysis. 
Microinjections into the NTS 
 After the exposure of the brainstem via dissection of the atlantooccipial the 
animals  were  allowed  to  stabilize  for  at  least  30   minutes   before   microinjections.  
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Unilateral microinjections of CPA (330 pmol in 50 nl of artificial cerebrospinal fluid, ACF) 
were made through multibarrel glass micropipettes into the medial region of the caudal 
subpostremal NTS as described previously(7; 68; 74-76).  This dose of CPA produced most 
consistent, predominantly pressor responses in our previous study(76).  The CPA was 
dissolved in ACF and the pH adjusted to 7.2.  In several previous studies we have 
shown that microinjections of the same amount of vehicle (ACF) into the same site of 
the NTS did not markedly affect MAP, HR, RSNA, LSNA and pre-ganglionic adrenal 
sympathetic nerve activity (pre-ASNA) and regional vascular blood flows(7; 67; 71; 73-76).  






















































Figure 11.   Microinjection sites in the caudal subpostremal NTS for all experiments.  Schematic 
diagrams of transverse sections of the medulla oblongata from a rat brain.  NTS, nucleus tractus 
solitarii; AP, area postrema;  c, central canal; 10, dorsal motor nucleus of the vagus nerve; 12, 
nucleus of the hypoglossal nerve; Ts, tractus solitarius; Gr, gracile nucleus; Cu, cuneate 
nucleus.  Scale is shown at the bottom; the number on the left side of the schematic diagram 
denotes the rostro-caudal position in millimeters of the section relative to the obex according to 
the atlas of the rat subpostremal NTS by Barraco et al. (3).  Microinjection sites were marked 
with fluorescent dye and are denoted with the following symbols A: microinjections of CPA in 
intact animals (ʀ), after bilateral adrenalectomy (U), and following ȕ-adrenergic blockade (ɿ).  
B:  microinjections of CPA after V1 vasopressin receptor blockade (Ƒ), following bilateral 
sinoaortic denervation (), after combined adrenalectomy and V1 vasopressinergic blockade (Ŷ) 
and following combined sinoaortic denervation and adrenalectomy ().
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natural, random fluctuations of these variables over the time of measurements.  To 
avoid the effect of desensitization of A1 adenosine receptors, in all experiments only one 
dose of the agonist was microinjected into left or right side of the NTS.  All 
microinjection sites were verified histologically (Figure 11). 
Experimental protocols 
 Comparing regional vascular responses obtained in intact vs. specific 
experimental conditions, we evaluated the specific contribution of three major 
vasoactive factors (E-adrenergic vasodilation vs. sympathetic and vasopressinergic 
vasoconstriction) to the responses of somatic (iliac) vs. visceral (mesenteric and renal) 
vascular beds evoked by selective activation of A1 adenosine receptors in the NTS.  Our 
previous studies showed that only these three vasoactive factors significantly 
contributed to iliac vascular responses evoked by stimulation of NTS A1 adenosine 
receptors. 
 Basic experimental protocols allowed for comparisons of how elimination of one 
vasoactive factor affects the responses observed in intact animals.  However, selective 
denervation of each vascular bed, which would allow for selective removal of the 
sympathetic component of the responses, was extremely difficult and in a few 
successful experiments arterial pressure was markedly lower than in other experimental 
groups (<70 mmHg).  Therefore we evaluated the contribution of sympathetic 
vasoconstriction alone to the regional vascular responses indirectly by removing the 
adrenal and vasopressinergic components of the responses via adrenalectomy 
combined with systemic V1 vasopressinergic blockade (Protocol 5).  Adrenalectomy and 
E-adrenergic blockade (Protocols 1 and 2, respectively) removed E-adrenergic 
vasodilation; therefore, these protocols showed how sympathetic and vasopressinergic 
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vasoconstriction triggered by activation of NTS A1 adenosine receptors affected regional 
vascular beds. Blockade of V1 vasopressinergic receptors (Protocol 3) removed the 
vascular action of vasopressin; therefore, showed how regional vascular beds respond 
to E-adrenergic vasodilation opposed by sympathetic vasoconstriction. The contribution 
of the vasopressinergic component alone to the regional vascular responses was 
evaluated by subtracting sympathetic vasoconstriction (evaluated in Protocol 5) from 
combined vasopressinergic and sympathetic vasoconstriction (Protocol 1).  The 
contribution of E-adrenergic vasodilation alone to the regional vascular beds responses 
was evaluated by subtracting sympathetic vasoconstriction (Protocol 5) from combined 
sympathetic neural and adrenergic responses (evaluated in Protocol 3).  To evaluate 
separate effects of each humoral factor we subtracted the sympathetic component of 
the responses (averaged values obtained in Protocol 5) from each single animal 
response in Protocols 1 and 3 and then averaged the data in each experimental group.   
 In addition, sinoaortic denervation (Protocol 4), which removed baroreflex 
vasopressinergic and sympathetic vasoconstriction and the baroreflex dependent part of 
the activation of the adrenal medulla, evaluated the relative regional vasodilation 
mediated via the non-baroreflex component of the activation of the adrenal medulla(76).  
Finally, sinoaortic denervation combined with bilateral adrenalectomy removed all three 
major vasoactive factors triggered by NTS A1 adenosine receptor stimulation.  This 
protocol tested if the three vasoactive factors (sympathetic and vasopressinergic 
vasoconstriction opposed by E-adrenergic vasodilation), known to affect the somatic 
(iliac) vascular bed(47; 48), are the only major factors affecting visceral vascular beds 




 The regional vascular conductance was calculated similarly as in our previous 
studies by dividing the regional blood flows, expressed as Doppler shift (in Hz), by MAP 
(in mmHg)(47; 48).  The absolute values of vascular conductance depend to some extent 
on positioning of the probe around the arteries; therefore comparisons between the 
relative changes were more reliable.  In all experimental groups the hemodynamic data 
were averaged in 1 min intervals over a 20 min period of the response. Since the 
responses were biphasic: initial decrease in MAP and vasodilation (~ first 5 min of the 
response) followed by the pressor and vasoconstrictor phase of the response (last ~15 
min).  In addition we calculated the overall responses for each vascular bed calculating 
the integral of the response for first 5 min of the responses, where vasodilation 
prevailed, and the last 15 min of the responses, where vasoconstriction prevailed. To 
make the integral values comparable between the phases of the responses we 
normalized the integral values to one minute by dividing the total integral for the first and 
second phase of the response by 5 and 15, respectively.  
 Two way ANOVA was used to evaluate the relative contribution of the three 
vasoactive factors (sympathetic and vasopressinergic vasoconstriction opposed by E-
adrenergic vasodilation) to the responses of the three vascular beds (iliac, mesenteric 
and renal) in respect to the integral responses. Two way ANOVA was also used for 
comparing the dynamics of the response in each vascular bed observed under each 
experimental condition, and for each single vasoactive factor (20 time points of the 
responses vs. 3 vascular beds).  A t-test with Bonferroni adjustments was used for the 
calculation of specific differences between the groups for those comparisons where 
interactions of the vasoactive factors or the time vs. the vascular beds were significant. 
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Data are means ±SE; n=number of rats.  Resting values for intact (INT) animals and following: bilateral 
adrenalectomy (ADX), ȕ-adrenergic blockade (ȕX), vasopressin V1 receptor blockade (VX), adrenalectomy +V1 
receptor blockade (ADX+VX), sinoaortic denervation (SAD) and sinaortic denervation + adrenalectomy (SAD+ADX). 
*P<0.05 VS INTACT. P<0.05: † Iliac vs. mesenteric, ‡ Iliac vs. renal, • Mesenteric vs. renal.








beats/min Blood Flow, Hz Vascular Conductance, Hz/mmHg 
    Iliac Mesenteric Renal Iliac Mesenteric Renal 




826.6±63.1†‡ 1228.4±72.3 1771.9±213.7 9.3±1.0†‡ 13.7±1.2 19.3±2.2 
ADX 8 82.3±1.8 336.1±16.3 834.4±68.7†‡ 1344.0±169.7• 2283.6±215.2 10.3±0.9†‡ 16.4±2.0• 27.8±2.5* 
ßX 7 92.1±3.8 300.0±7.5 697.0±71.3‡ 1424.8±138.8 1761.4±307.3 7.6±0.7‡ 15.5±1.3 19.3±3.6 
VX 7 81.2±2.6 351.7±22.3 997.0±194.4‡ 1184.6±129.8• 2685.2±123.5* 12.5±2.6‡ 14.6±1.5• 33.1±1.3* 
SAD 7 86.1±5.7 386.7±16.3* 732.4±86.8‡ 1150.7±163.7 1609.9±200.2 8.7±1.2†‡ 13.6±1.9 18.7±2.1 
ADX+VX 8 76.5±2.7* 341.8±10.1 1554.6±149.1* 1384.8±154.4 1550.9±153.3 20.6±2.2* 18.6±2.4 20.3±1.9 






 Resting values of MAP, HR, iliac, mesenteric and renal blood flow and 
conductance for each experimental group, measured just before stimulation of NTS A1 
adenosine receptors, are presented in Table 6.  In most cases vascular conductance 
observed in specific beds in all experimental groups was not different from that 
observed in intact animals; the only exemptions were the increase in iliac vascular 
conductance following bilateral adrenalectomy combined with V1 vasopressinergic 
blockade and a smaller increase in renal conductance following V1 adrenalectomy alone 
and vasopressinergic blockade alone.  Therefore changes in the relative vascular 
responses evoked by activation of NTS A1 adenosine receptors were comparable 
across the experimental groups with only small limitations.  HR was significantly higher 
in the two groups where sinoaortic denervation was performed, as expected.  MAP was 
lower compared to intact animals only in two experimental groups: following bilateral 
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Data are means r SE; n = number of rats.  Beta adrenergic blockade (EX), Vasopressin V1 receptor blockade (VX). P<0.05:† Iliac 
vs. mesenteric, ‡ Iliac vs. renal.  No significant differences between mesenteric vs. renal vascular beds were observed. 
 
Table 7.  Average maximum hemodynamic responses evoked by E-adrenergic and V1 vasopressinergic blockades. 
¨% Iliac  ¨% Mesenteric ¨% Renal Experimental 
procedure n ¨%MAP ¨%HR Vascular Conductance 
EX 7 19.2±4.0 -8.6±1.6 -30.3±4.2†‡ -16.2±4.0 -13.0±3.3 
VX 8 -16.6±4.7 6.1±4.0 38.4±9.9 26.7±6.3 25.9±7.4 
ADX + VX  8 -30.6±5.2 12.9±5.0 55.6±11.7†‡ 38.4±7.4 27.9±8.6 
 
adrenalectomy combined with V1 vasopressinergic blockade or adrenalectomy 
combined with sinoaortic denervation.  
 The maximal effects evoked by E-adrenergic and V1 vasopressinergic blockades 
in the regional vascular beds and MAP are presented in Table 7.  Note that iliac 
vasoconstriction in response to E-adrenergic blockade was approximately twice as large 
as that observed in the mesenteric and renal vascular beds.  This suggests larger tonic 
E-adrenergic vasodilation in the iliac vs. both visceral vascular beds.  In contrast, no 
significant differences between the regional vascular beds were observed in response 
to V1 vasopressinergic blockade. 
Comparison of hemodynamic responses observed in intact vs. experimental groups 
 Figure 12 presents comparisons of averaged responses evoked by selective 
stimulation of NTS A1 adenosine receptors in intact animals and following specific 
experimental procedures.  Two way ANOVA showed significant differences between all 
experimental vs. intact conditions except for MVC in adrenalectomized animals and 
RVC following combined adrenalectomy plus vasopressinergic blockade, which did not 
reach statistical significance (P=0.195 and P=0112, respectively) (Figure 12).  In intact 
animals the typical variability of the responses to stimulation of NTS A1 adenosine 
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Figure 12.  Mean arterial pressure (MAP), iliac (IVC), mesenteric (MVC) and renal (RVC) vascular 
conductance responses to microinjection of adenosine A1 receptor agonist (CPA, 330 pmol/50 nl) into the 
subpostremal NTS in intact rats (-ż-, open circles) compared to the responses evoked following different 
experimental procedures (-Ɣ-, filled circles). Data are means ± SE.  *P<0.05 vs. intact animals.  
Abbreviations: bilateral adrenalectomy (ADX), ȕ-adrenergic blockade (ȕX), vasopressin V1 receptor 
blockade (VX), bilateral sinoaortic denervation (SAD), bilateral adrenalectomy + vasopressin V1 receptor 
blockade (ADX+VX) and bilateral sinoaortic denervation + bilateral adrenalectomy (SAD+ADX). 
laboratory(47; 48; 76).  In the initial phase of the responses (approximately first 5 minutes) 
depressor and vasodilatory responses prevailed. In the subsequent 15 minutes (or 
 
more) of the responses pressor and vasoconstrictor responses prevailed.  Overall, the 
increases in mean arterial pressure (MAP) and vasoconstriction in all vascular beds 
dominated over 20 minutes of the responses in the intact group.  Adrenalectomy and E-
adrenergic blockade eliminated initial vasodilation thus sympathetic and 
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vasopressinergic vasoconstriction dominated in these groups.  Blockade of V1 
vasopressinergic receptors virtually eliminated the vasoconstrictor component of the 
responses; adrenergic vasodilation prevailed over sympathetic vasoconstriction in this 
setting in all vascular beds.  Sinoaortic denervation eliminated reflex sympathetic 
vasoconstriction and vasopressin release(48; 76).  In this situation non-baroreflex 
activation of the adrenal medulla(76) was smaller than the activation mediated via 
combined baro- and non-baroreflex mechanisms; however, in this setting the 
vasodilatory factor was not opposed by any vasoconstricting factors (sympathetic 
nerves and vasopressin).  Therefore, vasodilation observed in this group did not differ 
substantially compared to that observed after blockade of V1 vasopressin receptors 
alone.  Combined adrenalectomy and V1 vasopressinergic blockade eliminated both 
major humoral factors, revealing that the contribution of sympathetic vasoconstriction to 
the responses was very small, especially in the mesenteric and renal vascular beds.  
Finally, combined sinoaortic denervation and bilateral adrenalectomy eliminated all 
three primary vasoactive factors triggered by stimulation of NTS A1 adenosine 
receptors and these residual responses were not different from those where only 
sympathetic nerves were active.  Since in most of the experimental groups more than 
one vasoactive factor was at play, the relative comparisons of the effect of the 
vasoactive factors on regional vascular beds was rather complex, especially that these 
factors may differentially interact with each other in a specific vascular bed.  To simplify 
the picture we further compared regional vascular responses due to the separate effects 
of sympathetic nerves, vasopressin and epinephrine; these single factor effects were  





Differential regional vascular responses to single vasoactive factors triggered by 
stimulation of NTS A1 adenosine receptors 
 Figure 13 compares the averaged responses of three vascular beds (iliac vs. 
mesenteric vs. renal) mediated via the three major vasoactive factors (sympathetic 
nerves, vasopressin and epinephrine) activated by the selective stimulation of A1 
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Figure 13. Comparison of regional hemodynamic responses (iliac, mesenteric and renal) mediated via 
three major vasoactive factors (sympathetic nerves, vasopressin and epinephrine) triggered by selective 
stimulation of A1 adenosine receptors located in the NTS (microinjections of CPA, 330 pmol/50 nl).  Data 
are means ± SE.  *, P<0.05 renal vs. iliac and mesenteric vascular beds.  Abbreviations as in Figure 2.  
Single factor effects were calculated from basic experimental groups: sympathetic nerve effect (ADX+VX), 
vasopressin ((ADX-(ADX+VX)), epinephrine ((VX-(ADX+VX)), and epinephrine released via non-baroreflex 
mechanism following sinoaortic denervation (SAD). These effects are compared to combined effect of all 




bed was compared with the combined impact of all these factors in intact animals and 
with a "negative control" group where activation of all these factors was prevented via 
combined bilateral sinoaortic denervation and adrenalectomy (SAD+ADX).  Two way 
ANOVA did not show significant differences between time-courses of regional vascular 
responses evoked by each vasoactive factor alone (P>0.05 for vascular bed x time 
interactions).  Nevertheless, all these factors acting together in intact animals revealed 
significantly smaller vasoconstriction in renal vs. both the iliac and mesenteric vascular 
beds, especially so in the later phase of the responses (P=0.024 for vascular beds x 
time interaction) (Figure 13, first upper panel).  The lack of differences between time-
courses of whole vascular responses to single vasoactive factors were not surprising 
taking into consideration the biphasic dynamics of the responses: E-adrenergic 
vasodilation prevailed in first 5 min of the responses whereas neural and 
vasopressinergic vasoconstriction prevailed in the remaining portion of responses.  The 
differences between regional vascular responses became significant when both phases 
of the responses were analyzed separately as an integral of the first 5 minutes (mostly 
vasodilation) and the last 15 minutes (mostly vasoconstriction) of the responses (Figure 
14 A and B).  In the initial phase of the responses (first 5 minutes) two way ANOVA 
showed significant vascular bed vs. experimental condition interaction (P=0.026), 
whereas in the later phase the regional vascular responses were more uniform (P= 
0.441 and P= 0.205 for vascular beds and vascular bed x experimental conditions 
interaction, respectively).  
 Interestingly, in the initial phase of the responses virtually no neural 
vasoconstriction was observed; the mesenteric vascular bed even tended to dilate 


















































































































Figure 14.  Integral hemodynamic responses (iliac, mesenteric and renal) evoked by selective stimulation 
of A1 adenosine receptors located in the NTS. Data were calculated from traces presented in Figure 3.  
Panel A, integrals measured over the first 5 min of the responses, when decreases in MAP and 
vasodilation prevailed. Panel B, integrals measured over the last 15 min of the responses, when increases 
in MAP and vasoconstriction prevailed. Data are means ± SE.  *, P<0.05 between vascular beds linked 
with the horizontal lines #P<0 05 vs zero Abbreviations as in Figure 2
significant (P=0.010 vs. zero) whereas renal and mesenteric vasoconstrictions remained 
very small and not different from zero.  Vasopressin initially evoked relatively small 
responses with significantly greater vasoconstriction in the mesenteric vs. the iliac and 
renal vascular beds (Figure 14A); however, in the later phase of the responses 
vasopressinergic vasoconstriction increased systematically and large, sustained 
vasoconstriction with no differences between the vascular beds was observed (Figure 
13, left upper panel).  In the initial phase of the responses iliac E-adrenergic vasodilation 
was significantly greater than that observed in the mesenteric vascular bed (P=0.020) 
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and tended to be greater than that observed in the renal vasculature (P=0.113) (Figure 
14A).  In the later phase of the responses these regional differences persisted to some 
degree (Figure 14B).  The regional effects of epinephrine released via non-baroreflex 
mechanisms (in sinoaortic denervated animals) were similar to those observed when 
the adrenal medulla was activated by both baro- and non-baroreflex mechanisms 
(Figures 13 and 14 A and B).  Finally, the elimination of all three vasoactive factors by 
means of combined bilateral sinoaortic denervation and adrenalectomy virtually 
abolished the responses in all vascular beds. 
DISCUSSION  
 Activation of A1 adenosine receptors in the NTS contributes to cardiovascular 
component of the hypothalamic defense response (HDR); specifically, it contributes to 
the inhibition of baroreflex transmission in the NTS and to the pressor component of 
HDR(71; 76; 80-82).  The present study tested the hypothesis that activation of NTS A1 
adenosine receptors may also contribute to the crucial component of HDR which is the 
redistribution of blood from the viscera to the muscle(93).   Therefore in the present study 
for the first time regional vascular responses evoked by selective stimulation of NTS A1 
adenosine receptors were compared.  Furthermore, we investigated the mechanisms 
mediating the complex hemodynamic responses and their regional variability.  The 
major finding of the present study is that three major vasoactive factors naturally 
triggered in response to the stimulation, i.e. sympathetic and vasopressinergic 
vasoconstriction counteracted by E-adrenergic vasodilation(47; 48), had differential effects 
on somatic (iliac) vs. visceral (mesenteric and renal) vasculatures.  Sympathetic 
vasoconstriction was observed in the iliac vasculature only. The greatest vasodilation 
mediated via released epinephrine and E-adrenergic mechanism was observed in the 
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iliac compared to the two other vascular beds.  The released vasopressin initially 
evoked small preferential mesenteric vasoconstriction, and then large, steady 
vasoconstriction, which was similar in all vascular beds.  Taken together these results 
suggest that A1 adenosine receptors operating in the NTS may contribute to the 
redistribution of blood from the visceral to the somatic (muscle) vasculature via 
preferential iliac vasodilation; however, two vasoconstricting factors simultaneously 
triggered by the stimulation diminished this effect by limiting skeletal muscle 
vasodilation.  When all vascular factors act simultaneously (intact group) 
vasoconstriction prevailed in the iliac and mesenteric vs. the renal vascular bed.  These 
data combined with previous studies from our laboratory and by others show that 
although the A1 adenosine receptors located in the NTS contribute to the pressor 
component of the stress/hypothalamic defense response, the activation of these 
receptors may have a small if any effect on the redistribution of blood from the visceral 
to the muscle vasculature(71; 76; 80-82). 
NTS adenosine receptors and differential control of regional vascular beds by neural 
and humoral factors:  Sympathetic nerves  
 It has been reported that stimulation of the superior laryngeal nerve, which 
conducts also the aortic depressor nerve fibers in rats, evokes much greater iliac than 
renal and mesenteric vasodilation(25).  Also stimulation of the aortic depressor nerve 
evoked preferential iliac vasodilation in rats(64). The activation of D1 adrenergic receptors 
(a major mechanism mediating sympathetic baroreflex responses) with metoxamine in 
mongrel dogs led to a greater vasoconstriction in iliac compared to renal and 
mesenteric vascular beds(34). Similarly, iliac capacity for baroreflex vasoconstriction and 
vasodilation in greyhounds was greater in iliac than mesenteric an renal vascular 
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beds(18). These reports suggested that baroreflex sympathetic responses may be 
greater in iliac than in renal and mesenteric vascular beds.  Therefore we expected that 
A1 adenosine receptor mediated inhibition of NTS baroreflex mechanisms(71; 76) will 
result in a greater sympathetic iliac vasoconstriction compared to that observed in 
mesenteric and renal vascular beds.  The present study generally confirmed this 
hypothesis. However, the lack of neural vasoconstrictor responses in renal and 
mesenteric vascular beds was unexpected (Figure 14A and B).  The neural 
vasoconstrictor component of the responses was relatively small in all vascular beds 
compared to the relatively large effects evoked by the increases in circulating 
epinephrine and vasopressin.  No significant vasoconstriction was observed in first 5 
min of the responses whereas in the later phase of the response (the last 15 min) only 
iliac vasoconstriction was significantly different from zero as well as from both other 
vascular beds, consistent with our previous reports(47; 48).   
 Interestingly, the mesenteric vascular bed tended to vasodilate and vasoconstrict 
in the initial and the later phase of the response, respectively, although the differences 
did not reach statistical significance vs. zero (P= 0.114 and P= 0.249, respectively).  
This may suggest that in the early phase of the responses sympathetic vasoconstriction 
was counteracted by neurogenic vasodilation and that this vasodilation weakened with 
time.  The most likely vasodilator factor responsible for this counteraction could be pre-
absorbed epinephrine released from sympathetic terminals, as suggested previously by 
Berecek and Brody(10).  The action of pre-absorbed epinephrine would decrease with 
time over the response in adrenalectomized animals.  Consistently sympathetic (D1-
adrenergic) vasoconstriction would increase with time as was observed.  This is also 
consistent with an initially smaller and then greater neural vasoconstriction in the iliac 
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vascular bed (Figure 14 A and B).  Among other vasodilatory neurotransmitters 
potentially released from sympathetic nerve terminals in the mesenteric and iliac 
vasculature, for example, nitric oxide (NO), calcitonin gene related peptide (CGRP) and 
adenosine as a catabolite of neuronally released ATP should be considered(13; 21; 43; 57). 
Vasopressin 
 In the present study we found that vasopressin triggered by selective activation 
of NTS A1 adenosine receptors initially constricts the mesenteric vascular bed to a 
greater extent than the renal and iliac vasculature, whereas in the later phase of the 
response no regional differences between vasopressinergic vasoconstriction were 
observed.  Our data are consistent with regional vascular responses observed following 
i.v. infusion of exogenous vasopressin in rats where small doses of vasopressin evoked 
preferential vasoconstriction in the mesenteric compared to the renal and iliac 
vasculature, whereas with larger doses the regional differences diminished or 
disappeared(28; 29).  It should be mentioned that regional effects of vasopressin in rats 
are different from those observed in dogs where vasopressinergic vasoconstriction 
dominates in the iliac vasculature(34; 45). Most likely in the present study the initial 
release of vasopressin was small and it increased with the time of the response 
(Figures 13 and 14).  In our previous study we found that the level of circulating 
vasopressin measured ~ 8 min after microinjection of A1 receptor agonist (CPA) into the 
NTS increased 4-fold compared to the resting level. Note that in the present study 
vasopressinergic vasoconstriction increased systematically up to ~ 8 min of the 
response and then was maintained at this high, steady level throughout the observed 
response (Figure 13 last upper panel).  Circulating vasopressin is quickly catabolized at 
normal body temperature(17); therefore, the large, sustained vasopressinergic 
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vasoconstriction observed in the present study suggests that vasopressin was 
continuously released into the circulation as long as the baroreflex mechanism was 
inhibited by stimulation of A1 adenosine receptors, which can last over an hour at this 
dose of A1 agonist (CPA, 330 pmol)(71). 
 In contrast to activation of NTS A1 adenosine receptors the activation of A2a 
adenosine receptors do not affect vasopressin release as A2a receptors do not inhibit 
baroreflex transmission in the NTS(37; 76).  In addition, previous studies from our 
laboratory showed that preferential iliac vasodilation observed after selective activation 
of NTS A2a adenosine receptors was completely abolished following bilateral 
adrenalectomy and lumbar sympathectomy and no vasoconstrictor component of the 
response persisted following these procedures(7; 42). 
Epinephrine 
 The preferential iliac vs. mesenteric and renal vasodilation dominated in the initial 
phase of the responses (Figures 13 and 14).  This vasodilation was mediated via 
activation of the adrenal medulla, release of epinephrine and E-adrenergic vasodilation.  
The initial vasodilation was abolished in all vascular beds after bilateral adrenalectomy 
or E-adrenergic blockade (Figure 12).   The greatest E-adrenergic vasodilation was 
observed in the iliac vascular bed, which supplies mostly skeletal muscles, compared to 
the vasodilation of both visceral vascular beds.  This is consistent with preferential 
expression of E-adrenergic receptors in the skeletal muscle vasculature(90) as well as 
with the greater tonic E-adrenergic vasodilation in iliac compared to mesenteric and 
renal vascular beds as observed in the present study (Table 7).  The preferential iliac 
vasodilation was observed in the group of animals where the whole epinephrine effect 
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was calculated from basic experimental groups ((VX-(ADX+VX)) as well as in the group 
where sinoaortic denervation was performed and non-baroreflex epinephrine effects 
were directly measured (Figures 13 and 14).  The consistent results obtained using the 
two different experimental approaches attested that the arithmetical separation of single 
vasoactive factors in the present study was accurate. 
 According to our previous reports sinoaortic denervation or blockade of 
glutamatergic transmission in the NTS abolishes pressor and regional 
sympathoexcitatory responses(76).  However, A1 receptor mediated activation of the 
adrenal medulla is only attenuated but not abolished in this setting.  Therefore, following 
sinoaortic denervation the adrenal medulla was still activated by stimulation of NTS A1 
adenosine receptors, although to a lesser extent than in intact animals where both baro- 
and non-baroreflex components of the activation of the adrenal medulla were present.   
In fact, in the present study regional vasodilatory responses evoked by combined baro- 
and non-baroreflex mechanisms tended to be greater compared to those where only 
non-baroreflex mechanism was active (Figure 14), although these differences did not 
reach statistical significance. 
 Preferential E-adrenergic iliac vasodilation, triggered by selective stimulation of 
NTS A1 adenosine receptors, was masked by simultaneous neural and 
vasopressinergic vasoconstriction.  However, combined activation of both A1 and A2a 
adenosine receptor subtypes in the NTS may significantly contribute to the preferential 
iliac vasodilation and to the redistribution of blood from visceral to somatic vascular 
beds.  Previous studies from our laboratory showed that selective stimulation of NTS 
A2a adenosine receptors evoked much greater iliac vs. renal and mesenteric 
vasodilation(7);  the E-adrenergic vasodilation contributed to ~80% of this preferential 
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iliac vasodilation(42).  
Potential Mechanisms 
 The present study showed that selective activation of NTS A1 adenosine 
receptors preferentially disinhibited vasopressin release and activated sympathetic 
outputs to the adrenal medulla, whereas other sympathetic outputs were activated to a 
much lesser extent.  What possible mechanism(s) may be responsible for this 
difference?  Our previous studies strongly suggested that A1 adenosine receptors act 
mainly via inhibition of baroreflex transmission in the NTS(71; 76).  This inhibition is 
responsible for all pressor and sympathoexcitatory responses including vasopressin 
release(48).  Since the vasopressinergic vasoconstriction observed in the present study 
was several fold greater than the regional sympathetic vasoconstriction, it seems that A1 
adenosine receptors may be located preferentially on those NTS baroreflex 
terminals/interneurons which are responsible for the tonic baroreflex restraint of 
vasopressin release and to a much lesser extent on NTS neurons responsible for tonic 
baroreflex restraint of regional sympathetic outputs.  In fact, the increases in lumbar and 
renal sympathetic nerve activity, observed in a previous study from our laboratory(76), 
were 2-3-fold smaller than that observed in the adrenal nerve.   
 One other reason for much smaller neural than humoral vasoconstriction 
observed in the present study may be the non-homogenous character of efferent 
sympathetic fibers selectively activated/disinhibited by A1 adenosine receptors in the 
NTS.  Efferent sympathetic terminals, in addition to the major neurotransmitter, 
norepinephrine, may secrete also several vasodilatory neurotransmitters including NO, 
CGRP, and ATP which after degradation to adenosine via ectonucleotidases may cause 
vasodilation via both A1 and A2a adenosine receptor subtypes(13; 20; 21; 43; 57; 94).   A1 
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adenosine receptors may disinhibit both vasoconstrictor and vasodilatory efferent fibers 
and these effects may cancel each other.  The net effect may be relatively small 
vasoconstriction (as observed in the iliac vasculature), no significant response (as 
observed in renal vasculature) or even a tendency to vasodilation (as observed in the 
mesenteric vascular bed).  In a previous study from our laboratory we observed a 
similar phenomenon revealed by selective stimulation of NTS A2a adenosine receptors.  
This stimulation triggered preferential iliac vasodilation, compared to the mesenteric and 
renal vasculatures, whereas sympathetic activity directed to the iliac vascular bed did 
not change in this setting(7; 73).  Taken together these observations could suggest that 
LSNA may not contribute to the response.  However, although the total LSNA did not 
alter, the lumbar sympathectomy did contribute to over 20% of the preferential iliac 
vasodilation suggesting that both vasoconstricting and vasodilatory fibers (most likely 
releasing NO) might have been simultaneously activated(21; 42; 57).  Which specific 
neurotransmitters are released from these regional sympathetic nerves in response to 
stimulation of NTS adenosine receptor subtypes awaits further investigation. 
 In absolute terms the regional E-adrenergic vasodilatory responses were much 
greater than the sympathetic vasoconstrictor responses, as blockade of V1 
vasopressinergic receptors reversed vasoconstriction (which dominated in intact 
animals) into marked vasodilation in all three vascular beds (Figure 12).  This indicated 
that E-adrenergic vasodilation markedly prevailed over sympathetic vasoconstriction in 
all vascular beds.  It should be stressed that NTS A1 adenosine receptors activate the 
adrenal medulla via both baroreflex and non-baroreflex mechanisms which is consistent 
with the greater overall activation of ASNA compared to other sympathetic outputs(76).  
The baroreflex component of this response was relatively weak (similarly as it was 
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observed for baroreflex-mediated regional vasoconstriction discussed above) as there 
were no significant differences between total vs. non-baroreflex E-adrenergic 
vasoconstriction observed in each vascular bed in these two situations (Figure 14).  The 
non-baroreflex component of the activation of the adrenal medulla is most likely 
mediated via descending pathways from hypothalamic nuclei which utilize 
nonglutamatergic neurotransmitters as we proposed previously(77).  However, specific 
pathways and neurotransmitters responsible for non-baroreflex activation of the adrenal 
medulla remain unknown.  All the above hypotheses should be addressed in future 
studies. 
Limitations of the method 
 Anesthesia and recent surgical stress most likely elevated resting levels of 
sympathetic activity, circulating epinephrine and vasopressin.  This could attenuate 
further increases of these vasoactive factors due to stimulation of NTS A1 adenosine 
receptors.  In fact, in our previous study, which was performed under similar 
experimental conditions, the resting vasopressin levels were moderately elevated 
compared with the levels measured in conscious animals(12; 32; 35; 48; 53; 54).  Nevertheless, 
the activation of NTS A1 adenosine receptors evoked large (over 4-fold) increase of 
circulating vasopressin compared to the elevated baseline(48).  Also regional 
sympathetic outputs, especially that directed to the adrenal medulla, were significantly 
activated in response to stimulation of NTS A1 adenosine receptors(76).  This attests that 
despite of the increased resting levels of humoral and neural factors the stimulation of 
NTS A1 receptors is potent to evoke marked responses in all these factors.  In addition, 
the potential effects of anesthesia and recent surgery presumably affected all vascular 
beds similarly; therefore we believe that the relative regional differences in 
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responsiveness to the vasoactive factors were preserved under these experimental 
conditions.  
 In this and our previous study, MAP decreased following V1 vasopressinergic 
blockade and was allowed to return spontaneously toward resting levels.  We did not 
compensate for the decrease of MAP with phenylephrine infusion to avoid potentially 
different D1 adrenergic vasoconstriction of different vascular beds due to differential 
regional expression of these receptors(34; 36);  such a compensation could distort the 
responses to the experimental factors.  The baroreflex compensation of the depressor 
response evoked by V1 vasopresinergic blockade probably elevated baseline 
sympathetic activity which may have attenuated the sympathoactivation in response to 
stimulation of NTS A1 adenosine receptors.  Therefore, the neural sympathetic 
component of the responses could be underestimated in this study.  Nevertheless, we 
believe that regional differences in sympathetic responses were preserved, as 
vasoconstriction in the iliac vascular bed significantly increased whereas the responses 
of the mesenteric and renal vascular beds were not different from zero.   
 Adrenalectomy and E-adrenergic blockade most likely diminished cardiac output 
regulatory capacity.  Therefore, following combined adrenalectomy and V1 
vasopressinergic blockade (Protocol 5) MAP and IVC did not fully recover, whereas 
following V1 vasopressinergic blockade alone (Protocol 3) full recovery of these 
parameters was observed (Table 6). 
 Renal auto-regulation was most likely responsible for much smaller responses 
evoked in this vascular bed in intact animals and under most of the experimental 
conditions (Figure 14).  Nevertheless, vasopressin had a relatively large effect on the 
renal vasculature, not different from that observed in the iliac and mesenteric 
  
74
vasculature beds during the whole time-course of the responses (Figure 13).  
Consistently, following V1 vasopressinergic blockade significantly increased renal 
vascular conductance remained significantly elevated compared to that observed in 
intact animals whereas MAP, IVC and MVC completely recovered following the 
blockade (Table 6). 
 Although we used a standard method of recording regional vascular 
conductance, which is well established in our laboratory, the relatively small neural vs. 
humoral regional vascular responses could raise a question if sympathetic nerves were 
potentially damaged during the procedure.  This was rather unlikely, because electrical 
stimulation of the aortic depressor nerve (8V, 0.1 ms, 8-64 Hz) and activation of 
cardiopulmonary receptors with i.v. phenylbiguanide (1-8 Pg/kg) applied in some intact 
animals evoked large sympathetic vasodilation in all vascular beds with patterns similar 
to that described previously by Faber and Brody(25).  
Conclusions 
 Three major vasoactive factors triggered by stimulation of NTS A1 adenosine 
receptors in the NTS (sympathetic and vasopressinergic vasoconstriction opposed by E-
adrenergic vasodilation) differentially affect regional vascular beds.  The E-adrenergic 
vasodilation, which dominates in the initial phase of the response, was significantly 
greater in the iliac than the mesenteric and renal vasculatures.  Significant sympathetic 
vasoconstriction was observed in the iliac but not in the mesenteric and renal vascular 
beds.  In contrast, vasopressin exerted marked, sustained vasoconstriction similar in all 
vascular beds, except for a small, initial preferential mesenteric vasoconstriction.  This 
pattern of regional vascular responses suggests that activation of A1 adenosine 
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receptors in the NTS has minor, if any, effect on redistribution of blood from the visceral 
to somatic (muscle) vasculature. 
Perspectives 
 Previous studies from our laboratory and by others strongly suggested that 
adenosine operating via A1 adenosine receptors in the NTS may contribute to the 
pressor component of hypothalamic defense response, most likely via the inhibition of 
baroreflex transmission in the NTS which disinhibits efferent sympathetic 
vasoconstriction and vasopressin release(48; 71; 76; 80-82).  Adenosine operating in the NTS 
via both A1 and A2a receptor subtypes preferentially activates the adrenal medulla 
leading to preferential iliac vasodilation(7; 42), which is the major mechanism mediating 
increases in blood supply to skeletal muscles during stress/HDR in the rat(93).  However, 
the present study showed that although activation of NTS A1 adenosine receptors 
preferentially increases iliac vascular conductance in the early phase of the response, 
this effect is overridden by the powerful V1 vasopressinergic vasoconstriction in later 
phase of the response, which diminished the contribution of NTS A1 adenosine 
receptors to the redistribution of blood. To what extent do these potential mechanisms, 
triggered by stimulation of NTS adenosine receptor subtypes, contribute to the pattern 
of autonomic responses evoked by the stress or HDR requires further investigation.  
Interestingly, some components of the autonomic responses evoked by selective 
activation of adenosine receptor subtypes in the NTS remain inconsistent with the 
pattern of HDR.  For example, the decreases in HR due to A1 and A2a adenosine 
receptor stimulation, the depressor responses evoked by A2a receptor stimulation, and 
the lack of contribution of NTS A2a receptors to the baroreflex inhibition are most likely 
components of other autonomic mechanisms, not related to the HDR. Alternatively, the 
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responses opposite to the HDR pattern may contribute to fine tuning of the HDR 
autonomic pattern. Further studies are necessary to specify the autonomic mechanisms 
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NEURAL AND HUMORAL CONTROL OF REGIONAL VASCULAR BEDS VIA A1 
ADENOSINE RECEPTORS LOCATED IN THE NUCLEUS OF THE SOLITARY 
TRACT 
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Previous studies from our laboratory showed that activation of NTS A1 adenosine 
receptors yields variable hemodynamic responses with prevailing pressor and iliac 
vasoconstrictor responses.  These responses are accompanied with differential 
activation of regional sympathetic activity (adrenal>>renallumbar) and inhibition of 
baroreflex mechanisms at the level of the NTS.  The variability of the hemodynamic 
responses was a result of simultaneous E-adrenergic vasodilation counteracted with 
sympathetic and unknown humoral vasoconstriction.  Among many potential 
vasoconstrictors vasopressin, angiotensin II and circulating norepinephrine were 
considered.  Therefore, blood pressure and iliac vascular responses evoked by 
selective stimulation of NTS A1 adenosine receptors (CPA 330 pmol/ 50 nl) in intact 
anesthetized (urethane/chloralose) Sprague Dawley rats were compared with the 
responses evoked following the blockade of each potential vasoconstrictor mechanism.  
I found that vasopressin is the major vasoconstrictor released into the circulation most 
likely as a result of A1-adenosine-receptor-mediated inhibition of baroreflex mechanism 
and disinhibition of tonic restraint of vasopressin release. Angiotensin II and circulating 
  
90
norepinephrine had virtually no contribution to the responses.  The direct evaluation 
confirmed that the levels of circulating vasopressin increased over 4-fold in response to 
stimulation of NTS A1 adenosine receptors. 
Since NTS A1 adenosine receptors contribute to the pressor component of the 
stress/hypothalamic defense (HDR) response it was interesting if these receptors 
contribute to the redistribution of blood from visceral (mesenteric and renal) to somatic 
(iliac) vascular beds, which is and integral part of HDR.  Therefore, regional vascular 
effects of three major vasoactive factors triggered by stimulation of NTS A1 adenosine 
receptors (E-adrenergic vasodilation opposed by sympathetic and vasopressinergic 
vasoconstriction) were compared; these vasoactive factors differentially affected the 
regional vascular beds.  The E-adrenergic vasodilation, which dominates in the initial 
phase of the response, was significantly greater in the iliac than the mesenteric and 
renal vasculatures.  Significant sympathetic vasoconstriction was observed in the iliac 
but not in the mesenteric and renal vascular beds.  In contrast, vasopressin exerted a 
marked, sustained vasoconstriction similar in all vascular beds.  This pattern of regional 
vascular responses suggests that activation of A1 adenosine receptors in the NTS has 
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